<!DOCTYPE HTML>

<html xmlns:mml="http://www.w3.org/1998/Math/MathML">

<head>
	<title>KoreaMed Synapse</title>
	<meta http-equiv="content-type" content="text/html; charset=utf-8">

	<script src="https://ajax.googleapis.com/ajax/libs/jquery/1.10.1/jquery.min.js"></script>

	<script type="text/javascript" src="https://crossmark.crossref.org/javascripts/v1.4/crossmark.min.js"></script>

<link href="https://ajax.googleapis.com/ajax/libs/jqueryui/1.10.3/themes/smoothness/jquery-ui.css" rel="stylesheet" type="text/css"/>
<script src="https://ajax.googleapis.com/ajax/libs/jqueryui/1.10.3/jquery-ui.min.js"></script>

	<script type="text/javascript" src="modernizr.js"></script>	
	<script type="text/javascript" async src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-MML-AM_CHTML"></script>
	<script type="text/x-mathjax-config"> 
	MathJax.Hub.Config({ 
		"HTML-CSS": { scale: 100, linebreaks: { automatic: true, width: "80% container"} }, 
		SVG: { linebreaks: { automatic:true } }, 
		displayAlign: "left" });
	</script>
	
	<script type="text/javascript" src="jcarousel/jquery.jcarousel.min.js"></script>	
	<link rel="stylesheet" type="text/css" href="jcarousel/skin.css?v=1467627375"/>		
	<link rel="stylesheet" type="text/css" href="css/goto.css?v=1467627359"/>

	<script>			

		jQuery(document).ready(function ($) {			
		
												
					var	aArticleSection = new  Array();							
				  	var	SectionNode = document.body.getElementsByTagName('a');
				  	var SectionCount = SectionNode.length;
				  	var output = '';
				  	
				  	for  ( var i = 0; i < SectionCount; i++ )
				  	{
				  		if  ( SectionNode[i].className == '__SECTION__' )
				  		{
				  			aArticleSection.push( SectionNode[i] );	        			
				  		}
				  	}
				  	
				  	for  ( var i = 0; i < aArticleSection.length; i++ )
				  	{
				  		var  MenuNode = aArticleSection[i].parentNode.getElementsByTagName('div');
				  		
				  		var  MenuItemNode = '';
				  		
				  		MenuItemNode += '<ul>';	        		
				  		for  ( var j = 0; j < aArticleSection.length; j++ )
				  		{
				  			MenuItemNode += '<li>'
				  			
				  			if  ( aArticleSection[i] == aArticleSection[j] )
				  			{
				  				MenuItemNode += decodeURIComponent( aArticleSection[j].name.slice( 14 ) );
				  			}
				  			else
				  			{
				    			MenuItemNode += '<a href="#'+aArticleSection[j].name+'">';
				    			MenuItemNode += decodeURIComponent( aArticleSection[j].name.slice( 14 ) );
				    			MenuItemNode += '</a>';
				    			MenuItemNode += '</li>'+'\n';
				    		}
				  		}
				  		
				  		MenuItemNode += '</ul>';
				  		
				  		MenuNode[0].innerHTML = MenuItemNode;
				  	}
				  	
				  	//
				  	// Supplement Material 정보를 생성한다
				  	//
				
					var	SMLink = '';
					
					$( ".supplementary-material-item" ).each( function( index, obj ) {					
																
						var	SMTitle = $( this ).find('span .tl-default').text();
						var	SMHref = $( this ).find('a[id^=S]').attr('href'); // ID 가 S 로 시작하는 HREF 를 LINK 주소로 지정한다
						
						var	SMMediaAttrNew = $( this ).find('.supplementary-material-media-attribute').text();
						var	SMMediaAttrOld = $( this ).find('sup').text();
						var	SMMediaAttr;
						
						if  ( SMMediaAttrNew != '' )
						{					
							SMMediaAttr = SMMediaAttrNew;
						}
						else
						{
							SMMediaAttr = SMMediaAttrOld;
						}
						
						
						if  ( SMTitle == '' )
						{
							SMTitle = 'Supplementary Material';
						}							
						
						SMLink += '<li>';					

						if ( ( 
						       SMMediaAttr.indexOf( 'avi' ) >= 0 ||
						       SMMediaAttr.indexOf( 'mp4' ) >= 0 ||
						       SMMediaAttr.indexOf( 'mpg' ) >= 0 ||
						       SMMediaAttr.indexOf( 'wmv' ) >= 0
						      ) 
						      &&
						      ( 
						      	Modernizr.video
						      )
						   ) 
						{  
							SMLink += SMTitle;							
							SMLink += '<div class="portlet_content_supplementary_materials_video">';	
													
							SMLink += '<div class="portlet_content_supplementary_materials_video_view">';
							SMLink += '<video controls>';
							SMLink += '<source src="'+SMHref+'&mode=preview" type=\'video/mp4; codecs="avc1.42E01E, mp4a.40.2"\'/>';
							SMLink += 'Your browser does not support the video tag.';					
							SMLink += '</video></div>';							
							SMLink += '<div>Thumbnail Video</div>';																																				
							SMLink += '<div style="margin-top:0.2em;"><a href='+SMHref+'>High Resolution Video '+SMMediaAttr+'</a></div>';
							SMLink += '</div>';
						}
						else
						{
							SMLink += '<a href='+SMHref+'>'+SMTitle+' '+SMMediaAttr+'</a>';
						}
						
						SMLink += '</li>';
					});
					
					$( '#portlet_content_supplementary_materials' ).append ( SMLink );								
					
					$(".goto").on("click", function(){
					  console.log("GOTO CLICK!");

					  deactivateAll(this);
					  toggle(this);
					});
					
					
					$(".MeSHTermMark").on("click", function(){
						var src;
						var title;
						var	meshflag;
						
						if  ( $(this).find("img").attr('src') === 'image/pin-off.gif')
						{
							src = 'image/pin-on.gif'							
							title = '';
							meshflag = 'mark';
						}
						else
						{
							src = 'image/pin-off.gif';
							title = 'Mark as inappropriate';
							meshflag = 'unmark';
						}
											
				        var DOI = $(this).parent().attr('data-id');
				        var MeSH = $(this).parent().attr('data-mesh');
				        var DataType = $(this).parent().attr('data-type');
				        
				        $.ajax({
					        type: "POST",
					        url: "https://www.koreamed.org/InternalCommunication.php",
					        data: "op=MeSHMark&id="+DOI+"&type="+DataType+"&data="+JSON.stringify( MeSH )+"&flag="+meshflag,
					        cache: false,
					        success: function(response) {
					    		}
					    });
					    
					    $( this ).find("img").attr("src", src );
						$( this ).find("img").attr("title", title );
					    
						return	false;
					});


					function toggle(elem) {
					  //$(elem).find("ul").toggle ("slide", {direction: "up"} );
					  $(elem).find("div").toggle ();
					  $(elem).toggleClass("active");
					}
					
					
					function deactivateAll(current) {
					  $( "div" ).each(function( index, elem ){
					      if (elem != current && $(elem).hasClass("active")) {
					          toggle(elem);
					      }
					  });
					}
					
					$('html').click(function() {
					deactivateAll( this );
					//Hide the gotos if visible
					});
					
					$('.goto').click(function(event) {
					event.stopPropagation();
					});				
			
	
		        	$(function() {
		               	$("#query").autocomplete({
		                        source: "QueryAutoComplete.php",
		                        minLength: 1,
		                        select: function(event, ui) {
		                                $('#query').val('"'+ui.item.value+'"');
		                                return  false;
		                                }
		                        });
		        	});	        
		});//]]>	        
        	
	</script>
	<meta name="citation_journal_title" content="Korean Journal of Radiology"/>
	<meta name="citation_title" content="In-Vivo Proton Magnetic Resonance Spectroscopy of 2-Hydroxyglutarate in Isocitrate Dehydrogenase-Mutated Gliomas: A Technical Review for Neuroradiologists"/>
	<meta name="citation_author" content="Kim, Hyeonjin"/>
	<meta name="citation_author_institution" content="Department of Radiology, Seoul National University Hospital, Seoul 03080, Korea">
	<meta name="citation_author_institution" content="Department of Biomedical Sciences, Seoul National University, Seoul 03087, Korea">
	<meta name="citation_author_institution" content="Institute of Radiation Medicine, Seoul National University Medical Research Center, Seoul 03080, Korea">
	<meta name="citation_author_email" content="hyeonjinkim@snu.ac.kr">
	<meta name="citation_author" content="Kim, Sungjin"/>
	<meta name="citation_author_institution" content="Department of Radiology, Seoul National University Hospital, Seoul 03080, Korea">
	<meta name="citation_author" content="Lee, Hyeong Hun"/>
	<meta name="citation_author_institution" content="Department of Biomedical Sciences, Seoul National University, Seoul 03087, Korea">
	<meta name="citation_author" content="Heo, Hwon"/>
	<meta name="citation_author_institution" content="Department of Biomedical Sciences, Seoul National University, Seoul 03087, Korea">
	<meta name="citation_date" content="2016/10/01"/>
	<meta name="citation_volume" content="17"/>
	<meta name="citation_issue" content="5"/>
	<meta name="citation_firstpage" content="620"/>
	<meta name="citation_lastpage" content="632"/>
	<meta name="citation_doi" content="10.3348/kjr.2016.17.5.620"/>
	<meta name="citation_issn" content="1229-6929"/>
	<meta name="citation_pdf_url" content="http://synapse.koreamed.org/Synapse/Data/PDFData/0068KJR/kjr-17-620.pdf"/>
	<meta name="citation_language" content="English"/>
	<meta name="citation_keywords" content="Proton; Magnetic Resonance Spectroscopy; mRS; Isocitrate Dehydrogenase; 2-hydroxyglutarate; Glioma; mutation"/>
	<meta name="citation_reference" content="citation_title=Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging; citation_author=M Law; citation_author=S Yang; citation_author=H Wang; citation_author=JS Babb; citation_author=G Johnson; citation_author=S Cha; citation_journal_title=AJNR Am J Neuroradiol; citation_volume=24; citation_pages=1989-1998; citation_date=2003;"/>
	<meta name="citation_reference" content="citation_title=Clinical application of proton magnetic resonance spectroscopy in the diagnosis of intracranial mass lesions; citation_author=W Möller-Hartmann; citation_author=S Herminghaus; citation_author=T Krings; citation_author=G Marquardt; citation_author=H Lanfermann; citation_author=U Pilatus; citation_journal_title=Neuroradiology; citation_volume=44; citation_pages=371-381; citation_date=2002;"/>
	<meta name="citation_reference" content="citation_title=In vivo imaging of glucose consumption and lactate concentration in human gliomas; citation_author=K Herholz; citation_author=W Heindel; citation_author=PR Luyten; citation_author=JA denHollander; citation_author=U Pietrzyk; citation_author=J Voges; citation_journal_title=Ann Neurol; citation_volume=31; citation_pages=319-327; citation_date=1992;"/>
	<meta name="citation_reference" content="citation_title=Associations among magnetic resonance spectroscopy, apparent diffusion coefficients, and image-guided histopathology with special attention to radiation necrosis; citation_author=JP Rock; citation_author=L Scarpace; citation_author=D Hearshen; citation_author=J Gutierrez; citation_author=JL Fisher; citation_author=M Rosenblum; citation_journal_title=Neurosurgery; citation_volume=54; citation_pages=1111-1117; citation_date=2004;"/>
	<meta name="citation_reference" content="citation_title=Differentiating tumor recurrence from treatment necrosis: a review of neuro-oncologic imaging strategies; citation_author=N Verma; citation_author=MC Cowperthwaite; citation_author=MG Burnett; citation_author=MK Markey; citation_journal_title=Neuro Oncol; citation_volume=15; citation_pages=515-534; citation_date=2013;"/>
	<meta name="citation_reference" content="citation_title=Elevated citrate in pediatric astrocytomas with malignant progression; citation_author=S Blüml; citation_author=A Panigrahy; citation_author=M Laskov; citation_author=G Dhall; citation_author=MD Krieger; citation_author=MD Nelson; citation_journal_title=Neuro Oncol; citation_volume=13; citation_pages=1107-1117; citation_date=2011;"/>
	<meta name="citation_reference" content="citation_title=Metabolic profiles of human brain tumors using quantitative in vivo 1H magnetic resonance spectroscopy; citation_author=FA Howe; citation_author=SJ Barton; citation_author=SA Cudlip; citation_author=M Stubbs; citation_author=DE Saunders; citation_author=M Murphy; citation_journal_title=Magn Reson Med; citation_volume=49; citation_pages=223-232; citation_date=2003;"/>
	<meta name="citation_reference" content="citation_title=Proton magnetic resonance spectroscopy ((1) H MRS) of human brain tumours: assessment of differences between tumour types and its applicability in brain tumour categorization; citation_author=C Majós; citation_author=J Alonso; citation_author=C Aguilera; citation_author=M Serrallonga; citation_author=J Pérez-Martín; citation_author=JJ Acebes; citation_journal_title=Eur Radiol; citation_volume=13; citation_pages=582-591; citation_date=2003;"/>
	<meta name="citation_reference" content="citation_title=Multimodal MRI in the characterization of glial neoplasms: the combined role of single-voxel MR spectroscopy, diffusion imaging and echo-planar perfusion imaging; citation_author=P Zonari; citation_author=P Baraldi; citation_author=G Crisi; citation_journal_title=Neuroradiology; citation_volume=49; citation_pages=795-803; citation_date=2007;"/>
	<meta name="citation_reference" content="citation_title=An integrated genomic analysis of human glioblastoma multiforme; citation_author=DW Parsons; citation_author=S Jones; citation_author=X Zhang; citation_author=JC Lin; citation_author=RJ Leary; citation_author=P Angenendt; citation_journal_title=Science; citation_volume=321; citation_pages=1807-1812; citation_date=2008;"/>
	<meta name="citation_reference" content="citation_title=IDH1 and IDH2 mutations in gliomas; citation_author=H Yan; citation_author=DW Parsons; citation_author=G Jin; citation_author=R McLendon; citation_author=BA Rasheed; citation_author=W Yuan; citation_journal_title=N Engl J Med; citation_volume=360; citation_pages=765-773; citation_date=2009;"/>
	<meta name="citation_reference" content="citation_title=Cancer-associated IDH1 mutations produce 2-hydroxyglutarate; citation_author=L Dang; citation_author=DW White; citation_author=S Gross; citation_author=BD Bennett; citation_author=MA Bittinger; citation_author=EM Driggers; citation_journal_title=Nature; citation_volume=462; citation_pages=739-744; citation_date=2009;"/>
	<meta name="citation_reference" content="citation_title=Detection of oncogenic IDH1 mutations using magnetic resonance spectroscopy of 2-hydroxyglutarate; citation_author=OC Andronesi; citation_author=O Rapalino; citation_author=E Gerstner; citation_author=A Chi; citation_author=TT Batchelor; citation_author=DP Cahill; citation_journal_title=J Clin Invest; citation_volume=123; citation_pages=3659-3663; citation_date=2013;"/>
	<meta name="citation_reference" content="citation_title=Non-invasive detection of 2-hydroxyglutarate and other metabolites in IDH1 mutant glioma patients using magnetic resonance spectroscopy; citation_author=WB Pope; citation_author=RM Prins; citation_author=M Albert Thomas; citation_author=R Nagarajan; citation_author=KE Yen; citation_author=MA Bittinger; citation_journal_title=J Neurooncol; citation_volume=107; citation_pages=197-205; citation_date=2012;"/>
	<meta name="citation_reference" content="citation_title=Detection of 2-hydroxyglutarate in IDH-mutated glioma patients by in vivo spectral-editing and 2D correlation magnetic resonance spectroscopy; citation_author=OC Andronesi; citation_author=GS Kim; citation_author=E Gerstner; citation_author=T Batchelor; citation_author=AA Tzika; citation_author=VR Fantin; citation_journal_title=Sci Transl Med; citation_volume=4; citation_pages=116ra4; citation_date=2012;"/>
	<meta name="citation_reference" content="citation_title=2-hydroxyglutarate detection by magnetic resonance spectroscopy in IDH-mutated patients with gliomas; citation_author=C Choi; citation_author=SK Ganji; citation_author=RJ DeBerardinis; citation_author=KJ Hatanpaa; citation_author=D Rakheja; citation_author=Z Kovacs; citation_journal_title=Nat Med; citation_volume=18; citation_pages=624-629; citation_date=2012;"/>
	<meta name="citation_reference" content="citation_title=A comparative study of short- and long-TE H MRS at 3 T for in vivo detection of 2-hydroxyglutarate in brain tumors; citation_author=C Choi; citation_author=S Ganji; citation_author=K Hulsey; citation_author=A Madan; citation_author=Z Kovacs; citation_author=I Dimitrov; citation_journal_title=NMR Biomed; citation_volume=26; citation_pages=1242-1250; citation_date=2013;"/>
	<meta name="citation_reference" content="citation_title=Accumulation of 2-hydroxyglutarate in gliomas correlates with survival: a study by 3.0-tesla magnetic resonance spectroscopy; citation_author=M Natsumeda; citation_author=H Igarashi; citation_author=T Nomura; citation_author=R Ogura; citation_author=Y Tsukamoto; citation_author=T Kobayashi; citation_journal_title=Acta Neuropathol Commun; citation_volume=2; citation_pages=158; citation_date=2014;"/>
	<meta name="citation_reference" content="citation_title=Integration of 2-hydroxyglutarate-proton magnetic resonance spectroscopy into clinical practice for disease monitoring in isocitrate dehydrogenase-mutant glioma; citation_author=MI de la Fuente; citation_author=RJ Young; citation_author=J Rubel; citation_author=M Rosenblum; citation_author=J Tisnado; citation_author=S Briggs; citation_journal_title=Neuro Oncol; citation_volume=18; citation_pages=283-290; citation_date=2016;"/>
	<meta name="citation_reference" content="citation_title=Detection of 2-hydroxyglutaric acid in vivo by proton magnetic resonance spectroscopy in U87 glioma cells overexpressing isocitrate dehydrogenase-1 mutation; citation_author=J Lazovic; citation_author=H Soto; citation_author=D Piccioni; citation_author=JR Lou; citation_author=S Li; citation_author=L Mirsadraei; citation_journal_title=Neuro Oncol; citation_volume=14; citation_pages=1465-1472; citation_date=2012;"/>
	<meta name="citation_reference" content="citation_title=Noninvasive quantification of 2-hydroxyglutarate in human gliomas with IDH1 and IDH2 mutations; citation_author=UE Emir; citation_author=SJ Larkin; citation_author=N de Pennington; citation_author=N Voets; citation_author=P Plaha; citation_author=R Stacey; citation_journal_title=Cancer Res; citation_volume=76; citation_pages=43-49; citation_date=2016;"/>
	<meta name="citation_reference" content="citation_title=On the utility of short echo time (TE) single voxel 1H-MRS in non-invasive detection of 2-hydroxyglutarate (2HG); challenges and potential improvement illustrated with animal models using MRUI and LCModel; citation_author=H Heo; citation_author=S Kim; citation_author=HH Lee; citation_author=HR Cho; citation_author=WJ Xu; citation_author=SH Lee; citation_journal_title=PLoS One; citation_volume=11; citation_pages=e0147794; citation_date=2016;"/>
	<meta name="citation_reference" content="citation_title=Cancer-associated IDH mutations: biomarker and therapeutic opportunities; citation_author=KE Yen; citation_author=MA Bittinger; citation_author=SM Su; citation_author=VR Fantin; citation_journal_title=Oncogene; citation_volume=29; citation_pages=6409-6417; citation_date=2010;"/>
	<meta name="citation_reference" content="citation_title=2-hydroxyglutarate as a magnetic resonance biomarker for glioma subtyping; citation_author=M Esmaeili; citation_author=R Vettukattil; citation_author=TF Bathen; citation_journal_title=Transl Oncol; citation_volume=6; citation_pages=92-98; citation_date=2013;"/>
	<meta name="citation_reference" content="citation_title=Hyperpolarized [1-13C] glutamate: a metabolic imaging biomarker of IDH1 mutational status in glioma; citation_author=MM Chaumeil; citation_author=PE Larson; citation_author=SM Woods; citation_author=L Cai; citation_author=P Eriksson; citation_author=AE Robinson; citation_journal_title=Cancer Res; citation_volume=74; citation_pages=4247-4257; citation_date=2014;"/>
	<meta name="citation_reference" content="citation_title=BCAT1 promotes cell proliferation through amino acid catabolism in gliomas carrying wild-type IDH1; citation_author=M Tönjes; citation_author=S Barbus; citation_author=YJ Park; citation_author=W Wang; citation_author=M Schlotter; citation_author=AM Lindroth; citation_journal_title=Nat Med; citation_volume=19; citation_pages=901-908; citation_date=2013;"/>
	<meta name="citation_reference" content="citation_title=Decreasing GSH and increasing ROS in chemosensitivity gliomas with IDH1 mutation; citation_author=J Shi; citation_author=B Sun; citation_author=W Shi; citation_author=H Zuo; citation_author=D Cui; citation_author=L Ni; citation_journal_title=Tumour Biol; citation_volume=36; citation_pages=655-662; citation_date=2015;"/>
	<meta name="citation_reference" content="citation_title=Analysis of tumor metabolism reveals mitochondrial glucose oxidation in genetically diverse human glioblastomas in the mouse brain in vivo; citation_author=I Marin-Valencia; citation_author=C Yang; citation_author=T Mashimo; citation_author=S Cho; citation_author=H Baek; citation_author=XL Yang; citation_journal_title=Cell Metab; citation_volume=15; citation_pages=827-837; citation_date=2012;"/>
	<meta name="citation_reference" content="citation_title=In vivo NMR spectroscopy: principles and techniques; citation_author=RA de Graaf; citation_pages=26-32; citation_date=2007; citation_publisher=John Wiley & Sons;"/>
	<meta name="citation_reference" content="citation_title=Metabolite-specific NMR spectroscopy in vivo; citation_author=PS Allen; citation_author=RB Thompson; citation_author=AH Wilman; citation_journal_title=NMR Biomed; citation_volume=10; citation_pages=435-444; citation_date=1997;"/>
	<meta name="citation_reference" content="citation_title=Proton NMR chemical shifts and coupling constants for brain metabolites; citation_author=V Govindaraju; citation_author=K Young; citation_author=AA Maudsley; citation_journal_title=NMR Biomed; citation_volume=13; citation_pages=129-153; citation_date=2000;"/>
	<meta name="citation_reference" content="citation_title=Localized high-resolution proton NMR spectroscopy using stimulated echoes: initial applications to human brain in vivo; citation_author=J Frahm; citation_author=H Bruhn; citation_author=ML Gyngell; citation_author=KD Merboldt; citation_author=W Hänicke; citation_author=R Sauter; citation_journal_title=Magn Reson Med; citation_volume=9; citation_pages=79-93; citation_date=1989;"/>
	<meta name="citation_reference" content="citation_title=Analysis of macromolecule resonances in 1H NMR spectra of human brain; citation_author=KL Behar; citation_author=DL Rothman; citation_author=DD Spencer; citation_author=OA Petroff; citation_journal_title=Magn Reson Med; citation_volume=32; citation_pages=294-302; citation_date=1994;"/>
	<meta name="citation_reference" content="citation_title=Parameterized evaluation of macromolecules and lipids in proton MR spectroscopy of brain diseases; citation_author=U Seeger; citation_author=U Klose; citation_author=I Mader; citation_author=W Grodd; citation_author=T Nägele; citation_journal_title=Magn Reson Med; citation_volume=49; citation_pages=19-28; citation_date=2003;"/>
	<meta name="citation_reference" content="citation_title=Improved analysis of 1H-MR spectra in the presence of mobile lipids; citation_author=DP Auer; citation_author=C Gössl; citation_author=T Schirmer; citation_author=M Czisch; citation_journal_title=Magn Reson Med; citation_volume=46; citation_pages=615-618; citation_date=2001;"/>
	<meta name="citation_reference" content="citation_title=Quantitative 1H-magnetic resonance spectroscopy of human brain: influence of composition and parameterization of the basis set in linear combination model-fitting; citation_author=L Hofmann; citation_author=J Slotboom; citation_author=B Jung; citation_author=P Maloca; citation_author=C Boesch; citation_author=R Kreis; citation_journal_title=Magn Reson Med; citation_volume=48; citation_pages=440-453; citation_date=2002;"/>
	<meta name="citation_reference" content="citation_title=Estimation of metabolite concentrations from localized in vivo proton NMR spectra; citation_author=SW Provencher; citation_journal_title=Magn Reson Med; citation_volume=30; citation_pages=672-679; citation_date=1993;"/>
	<meta name="citation_reference" content="citation_title=Handling macromolecule signals in the quantification of the neurochemical profile; citation_author=C Cudalbu; citation_author=V Mlynárik; citation_author=R Gruetter; citation_journal_title=J Alzheimers Dis; citation_volume=31; citation_issue=Suppl 3; citation_pages=S101-S115; citation_date=2012;"/>
	<meta name="citation_reference" content="citation_title=Semi-LASER 1 H MR spectroscopy at 7 Tesla in human brain: metabolite quantification incorporating subject-specific macromolecule removal; citation_author=J Penner; citation_author=R Bartha; citation_journal_title=Magn Reson Med; citation_volume=74; citation_pages=4-12; citation_date=2015;"/>
	<meta name="citation_reference" content="citation_title=Variability of metabolite yield using STEAM or PRESS sequences in vivo at 3.0 T, illustrated with myo-inositol; citation_author=H Kim; citation_author=RB Thompson; citation_author=CC Hanstock; citation_author=PS Allen; citation_journal_title=Magn Reson Med; citation_volume=53; citation_pages=760-769; citation_date=2005;"/>
	<meta name="citation_reference" content="citation_title=A new multiple quantum filter design procedure for use on strongly coupled spin systems found in vivo: its application to glutamate; citation_author=RB Thompson; citation_author=PS Allen; citation_journal_title=Magn Reson Med; citation_volume=39; citation_pages=762-771; citation_date=1998;"/>
	<meta name="citation_reference" content="citation_title=Product operator-formalism for the description of NMR pulse experiments; citation_author=OW Sørensen; citation_author=GW Eich; citation_author=MH Levitt; citation_author=G Bodenhausen; citation_author=RR Ernst; citation_journal_title=Prog NMR Spectrosc; citation_volume=16; citation_pages=163-192; citation_date=1983;"/>
	<meta name="citation_reference" content="citation_title=Automated spectral analysis I: formation of a priori information by spectral simulation; citation_author=K Young; citation_author=V Govindaraju; citation_author=BJ Soher; citation_author=AA Maudsley; citation_journal_title=Magn Reson Med; citation_volume=40; citation_pages=812-815; citation_date=1998;"/>
	<meta name="citation_reference" content="citation_title=Automated spectral analysis II: application of wavelet shrinkage for characterization of non-parameterized signals; citation_author=K Young; citation_author=BJ Soher; citation_author=AA Maudsley; citation_journal_title=Magn Reson Med; citation_volume=40; citation_pages=816-821; citation_date=1998;"/>
	<meta name="citation_reference" content="citation_title=Sources of variability in the response of coupled spins to the PRESS sequence and their potential impact on metabolite quantification; citation_author=RB Thompson; citation_author=PS Allen; citation_journal_title=Magn Reson Med; citation_volume=41; citation_pages=1162-1169; citation_date=1999;"/>
	<meta name="citation_reference" content="citation_title=Comparison of T(1) and T(2) metabolite relaxation times in glioma and normal brain at 3T; citation_author=Y Li; citation_author=R Srinivasan; citation_author=H Ratiney; citation_author=Y Lu; citation_author=SM Chang; citation_author=SJ Nelson; citation_journal_title=J Magn Reson Imaging; citation_volume=28; citation_pages=342-350; citation_date=2008;"/>
	<meta name="citation_reference" content="citation_title=Pitfalls in lactate measurements at 3T; citation_author=T Lange; citation_author=U Dydak; citation_author=TP Roberts; citation_author=HA Rowley; citation_author=M Bjeljac; citation_author=P Boesiger; citation_journal_title=AJNR Am J Neuroradiol; citation_volume=27; citation_pages=895-901; citation_date=2006;"/>
	<meta name="citation_reference" content="citation_title=Simultaneous in vivo spectral editing and water suppression; citation_author=M Mescher; citation_author=H Merkle; citation_author=J Kirsch; citation_author=M Garwood; citation_author=R Gruetter; citation_journal_title=NMR Biomed; citation_volume=11; citation_pages=266-272; citation_date=1998;"/>
	<meta name="citation_reference" content="citation_title=Homonuclear 1H double-resonance difference spectroscopy of the rat brain in vivo; citation_author=DL Rothman; citation_author=KL Behar; citation_author=HP Hetherington; citation_author=RG Shulman; citation_journal_title=Proc Natl Acad Sci U S A; citation_volume=81; citation_pages=6330-6334; citation_date=1984;"/>
	<meta name="citation_reference" content="citation_title=1H homonuclear editing of rat brain using semiselective pulses; citation_author=HP Hetherington; citation_author=MJ Avison; citation_author=RG Shulman; citation_journal_title=Proc Natl Acad Sci U S A; citation_volume=82; citation_pages=3115-3118; citation_date=1985;"/>
	<meta name="citation_reference" content="citation_title=Principles of nuclear magnetic resonance in one and two dimensions; citation_author=RR Ernst; citation_author=G Bodenhausen; citation_author=A Wokaun; citation_pages=400-427; citation_date=1987; citation_publisher=Oxford University Press;"/>
	<meta name="citation_reference" content="citation_title=Two-dimensional spectroscopy. Application to nuclear magnetic resonance; citation_author=WP Aue; citation_author=E Bartholdi; citation_author=RR Ernst; citation_journal_title=J Chem Phys; citation_volume=64; citation_pages=2229-2246; citation_date=1976;"/>
	<meta name="citation_reference" content="citation_title=Toward accurate quantification of metabolites, lipids, and macromolecules in HRMAS spectra of human brain tumor biopsies using LCModel; citation_author=KS Opstad; citation_author=BA Bell; citation_author=JR Griffiths; citation_author=FA Howe; citation_journal_title=Magn Reson Med; citation_volume=60; citation_pages=1237-1242; citation_date=2008;"/>
	<meta name="citation_reference" content="citation_title=Java-based graphical user interface for the MRUI quantitation package; citation_author=A Naressi; citation_author=C Couturier; citation_author=JM Devos; citation_author=M Janssen; citation_author=C Mangeat; citation_author=R de Beer; citation_journal_title=MAGMA; citation_volume=12; citation_pages=141-152; citation_date=2001;"/>
	<meta name="citation_reference" content="citation_title=Cram&#x00e9;r-Rao bounds: an evaluation tool for quantitation; citation_author=S Cavassila; citation_author=S Deval; citation_author=C Huegen; citation_author=D van Ormondt; citation_author=D Graveron-Demilly; citation_journal_title=NMR Biomed; citation_volume=14; citation_pages=278-283; citation_date=2001;"/>
	<meta name="citation_reference" content="citation_title=Profiling the effects of isocitrate dehydrogenase 1 and 2 mutations on the cellular metabolome; citation_author=ZJ Reitman; citation_author=G Jin; citation_author=ED Karoly; citation_author=I Spasojevic; citation_author=J Yang; citation_author=KW Kinzler; citation_journal_title=Proc Natl Acad Sci U S A; citation_volume=108; citation_pages=3270-3275; citation_date=2011;"/>
	<meta name="citation_reference" content="citation_title=MYC-driven accumulation of 2-hydroxyglutarate is associated with breast cancer prognosis; citation_author=A Terunuma; citation_author=N Putluri; citation_author=P Mishra; citation_author=EA Mathé; citation_author=TH Dorsey; citation_author=M Yi; citation_journal_title=J Clin Invest; citation_volume=124; citation_pages=398-412; citation_date=2014;"/>
	<meta name="citation_reference" content="citation_title=Recurring mutations found by sequencing an acute myeloid leukemia genome; citation_author=ER Mardis; citation_author=L Ding; citation_author=DJ Dooling; citation_author=DE Larson; citation_author=MD McLellan; citation_author=K Chen; citation_journal_title=N Engl J Med; citation_volume=361; citation_pages=1058-1066; citation_date=2009;"/>
	<meta name="citation_reference" content="citation_title=Mutations in the D-2-hydroxyglutarate dehydrogenase gene cause D-2-hydroxyglutaric aciduria; citation_author=EA Struys; citation_author=GS Salomons; citation_author=Y Achouri; citation_author=E Van Schaftingen; citation_author=S Grosso; citation_author=WJ Craigen; citation_journal_title=Am J Hum Genet; citation_volume=76; citation_pages=358-360; citation_date=2005;"/>
	<meta name="citation_reference" content="citation_title=Somatic mutations of IDH1 and IDH2 in the leukemic transformation of myeloproliferative neoplasms; citation_author=A Green; citation_author=P Beer; citation_journal_title=N Engl J Med; citation_volume=362; citation_pages=369-370; citation_date=2010;"/>
	<meta name="citation_reference" content="citation_title=The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate; citation_author=PS Ward; citation_author=J Patel; citation_author=DR Wise; citation_author=O Abdel-Wahab; citation_author=BD Bennett; citation_author=HA Coller; citation_journal_title=Cancer Cell; citation_volume=17; citation_pages=225-234; citation_date=2010;"/>
	<meta name="citation_reference" content="citation_title=Mutational analysis of IDH1 codon 132 in glioblastomas and other common cancers; citation_author=MR Kang; citation_author=MS Kim; citation_author=JE Oh; citation_author=YR Kim; citation_author=SY Song; citation_author=SI Seo; citation_journal_title=Int J Cancer; citation_volume=125; citation_pages=353-355; citation_date=2009;"/>
	<meta name="citation_reference" content="citation_title=The consensus coding sequences of human breast and colorectal cancers; citation_author=T Sjöblom; citation_author=S Jones; citation_author=LD Wood; citation_author=DW Parsons; citation_author=J Lin; citation_author=TD Barber; citation_journal_title=Science; citation_volume=314; citation_pages=268-274; citation_date=2006;"/>
	<meta name="citation_reference" content="citation_title=IDH1(R132) mutation identified in one human melanoma metastasis, but not correlated with metastases to the brain; citation_author=GY Lopez; citation_author=ZJ Reitman; citation_author=D Solomon; citation_author=T Waldman; citation_author=DD Bigner; citation_author=RE McLendon; citation_journal_title=Biochem Biophys Res Commun; citation_volume=398; citation_pages=585-587; citation_date=2010;"/>

	<meta property="og:title" content="In-Vivo Proton Magnetic Resonance Spectroscopy of 2-Hydroxyglutarate in Isocitrate Dehydrogenase-Mutated Gliomas: A Technical Review for Neuroradiologists">
	<meta property="og:url" content="https://doi.org/10.3348/kjr.2016.17.5.620">
	<meta property="og:image" content="http://synapse.koreamed.org/image/synapse-logo.gif">
	<meta property="og:type" content="article">
	<meta property="og:site_name" content="https://doi.org/10.3348/kjr.2016.17.5.620">
	<meta property="og:description" content="Kim H, et al. Korean J Radiol. 2016 Sep-Oct;17(5):620-632. https://doi.org/10.3348/kjr.2016.17.5.620">

	<meta name="dc.identifier" content="doi:10.3348/kjr.2016.17.5.620">
	<meta name = "format-detection" content = "telephone=no">
	<link rel="stylesheet" href="KoreaMedSynapse.css?v=1480232755">	<!-- "v=파일변경시간" 을 지정하여 웹브라우져에서 캐쉬된 파일이 아닌 변경된 CSS 파일을 사용하도록 강제화한다 -->
	<link rel="stylesheet" href="KoreaMedSynapseRef2.css">
	<script>
		(function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
		(i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
		m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
		})(window,document,'script','https://www.google-analytics.com/analytics.js','ga');

		ga('create', 'UA-100755984-1', 'auto');
		ga('send', 'pageview');
	</script>

</head>

<body leftmargin="0" topmargin="0" marginwidth="0" marginheight="0">

	<div class="grid">
		
		<div class="twelve_col shadow">
			
	<table width="100%" height="100% width=" border="0" cellpadding="0" cellspacing="0">
	<tr><td valign="top">

		<table width="100%" border="0" cellspacing="0" cellpadding="0">
		  <tr> 
			<td width="146" height="66" bgcolor="#f18101"><a href="index.php"><img src="image/banner_top_left.gif" border="0"></a></td>
			<td valign="middle">
			<table width="100%" border="0" cellspacing="0" cellpadding="0">
  <tr>
    <td><img src="../image/jtitle_0068kjr_j.jpg" border="0" usemap="#HeaderMap"></td>
  </tr>
</table>
<map name="HeaderMap">
  <area shape="rect" coords="10,4,575,30" href="http://www.kjronline.org/" target="_blank">
  <area shape="rect" coords="282,40,350,60" href="http://www.kjronline.org/index.php?body=AboutUs" target="_blank">
  <area shape="rect" coords="360,39,489,60" href="http://www.kjronline.org/index.php?body=Instruction" target="_blank">
  <area shape="rect" coords="502,40,575,60" href="https://mc.manuscriptcentral.com/kjr" target="_blank">
</map>
			</td>
		  </tr>
		</table>				
		<!-- BEGIN : ˻  -->
		<table width="100%" border="0" cellspacing="0" cellpadding="0">
		  <tr> 
			<td width="10" bgcolor="#f18101"></td>
			<td>
			<table width="100%" border="0" cellpadding="0" cellspacing="0">
			<TR>
			<TD>
			<TABLE class=text cellSpacing=0 cellPadding=2 width="100%" bgColor=#000000 border=0>
			  <TBODY>
				<TR>
						  <TD class=smallText>KoreaMed Synapse</TD>
				</TR>
			  </TBODY>
			</TABLE>
			</TD>
			</TR>
						<TR> 
				<TD height="10" bgcolor="#cccccc"></TD> 
			</TR>
						<TR>
			<TD>
			  <TABLE cellSpacing=0 cellPadding=1 width="100%" bgColor=#cccccc border=0 class="d">
			  <FORM name=FormSearch action="search.php" method="GET">
				<TBODY>
				<TR>				  
				  				</TBODY>
			  </FORM>
			  </TABLE>
			  </TD>
			</TR>
		</table>
		<!-- END : ˻  -->
	</td></tr>
	</table>
		
	<table height="100%" border="0" cellpadding="0" cellspacing="0">
	<tr>	
		<!-- BEGIN :  ޴  -->
		<td width="146" valign="top" bgcolor="#f18101">
			<TABLE width="136" border=0 align="right" cellPadding=0 cellSpacing=0 class="Menu">
                  <TBODY>
                    <TR> 
                      <TD height="15"></TD>
                    </TR>
                    <TR> 
                      <TD height="18">Synapse Services</TD>
                    </TR>
                    <TR> 
                      <TD height="18"><A href="index.php">Journal Browser</A></TD>
                    </TR>
                    <TR> 
                      <TD height="18"><A href="AdvancedSearch.php">Advanced Search</A></TD>
                    </TR>
                    <TR> 
                      <TD height="5"></TD>
                    </TR>
                    <TR> 
                      <TD height="9"><img src="image/menu_line.gif" width="132" height="12"></TD>
                    </TR>
                    <TR>
                      <TD height="5"></TD>
                    </TR>
                    <TR> 
                      <TD height="18">About Synapse</TD>
                    </TR>
                    <TR> 
                      <TD height="18"><A href="Overview.php">Overview</A></TD>
                    </TR>
                    <TR> 
                      <TD height="18"><A href="Help.php">Help</A></TD>
                    </TR>
                    <TR> 
                      <TD height="18"><A href="Disclaimer.php">Disclaimer</A></TD>
                    </TR>
                    <TR> 
                      <TD height="9">&nbsp;</TD>
                    </TR>
                    <TR> 
                      <TD height="18"><div align="center"><img src="image/QR-Synapse.png"></div></TD>
                    </TR>
                    <TR> 
                      <TD height="9"></TD>
                    </TR>
					<TR> 
                      <TD height="66" valign="top"> <A href="http://www.kamje.or.kr/" target=_new><IMG src="image/KAMJEicon.gif" border=0></A></TD>
                    </TR>
                    <TR> 
                      <TD height="35" valign="top"> <A href="https://www.koreamed.org/" target=_new><IMG src="image/KoreaMedicon.gif" border=0></A></TD>
                    </TR>
                    <TR> 
                      <TD height="35" valign="top"> <A href="http://www.komci.org/" target=_new><IMG src="image/Komciicon.gif" border=0></A></TD>
                    </TR>
					<TR> 
                      <TD height="37" valign="top"> <A href="http://kamje.or.kr/intro.php?body=KAMJE-Press" target=_new><IMG src="image/banner-KAMJE-Press.jpg" border=0></A></TD>
                    </TR>
                    <TR> 
                      <TD height="33" valign="top"> <A href="https://journals.koreamed.org/" target=_new><IMG src="image/Journalsicon.gif" border=0></A></TD>
                    </TR>
                    <TR> 
                      <TD height="35" valign="top"> <A href="http://worldwidescience.org/" target=_new><IMG src="image/banner_WWS.gif" border=0></A></TD>
                    </TR>
                    <TR> 
                      <TD height="41" valign="top"><a href="http://orcid.org/" target="_blank"><img src="image/banner_ORCID.gif" border="0"></a></TD>
                    </TR>
                    <TR> 
                      <TD height="38" valign="top"> <A href="http://crossref.org/" target=_new><img src="https://assets.crossref.org/logo/crossref-logo-landscape-200.svg" width="126" height="35" alt="Crossref logo" style="border=0; background-color: white;"></A></TD>
                    </TR>
					<TR> 
                      <TD height="58" valign="top"><img src="https://assets.crossref.org/logo/crossref-reference-linking-logo-200.svg" width="126" height="55" alt="Crossref Reference Linking logo" style="border=0; background-color: white;"></TD>
                    </TR>
                    <TR> 
                      <TD height="31" valign="top"> <A href="crossmark.php" target=_new><IMG src="image/CROSSMARK_Color_horizontal.svg" width="128" height="28" border="0"></A></TD>
                    </TR>
                    <TR> 
                      <TD height="35" valign="top"><a href="http://www.crossref.org/fundref" target="_blank"><img src="image/banner_fundref.gif" width="126" height="33" border="0"></a></TD>
                    </TR>
					<TR> 
                      <TD height="44" valign="top"> <A href="http://www.crossref.org/citedby.html" target=_new><img src="https://assets.crossref.org/logo/crossref-cited-by-linking-logo-200.svg" width="126" height="42" alt="Crossref Cited-by Linking logo" style="border=0; background-color: white;"></A></TD>
                    </TR>
                    <TR> 
                      <TD height="50" valign="top"><a href="crosscheck.php" target="_new"><img src="https://assets.crossref.org/logo/crossref-similarity-check-logo-200.svg" width="126" height="48" alt="Crossref Similarity Check logo" style="border=0; background-color: white;"></A></TD>
                    </TR>
					<TR> 
                      <TD height="35" valign="top"><IMG src="image/banner_tdm.jpg" border=0></TD>
                    </TR>
					<TR> 
                      <TD height="39" valign="top"><a href="https://www.nlm.nih.gov/mesh/MeSHonDemand.html" target="_new"><IMG src="image/banner_mesh.png" border=0></a></TD>
                    </TR>
                    <TR> 
                      <TD height="300">&nbsp;</TD>
                    </TR>
                  </TBODY>
                </TABLE>
		</td>
		<!-- END :  ޴  -->
	

		<!-- BEGIN :  ˻     -->	
		<td width="730 height="100%" valign="top">
		<table width="100%" border="0 cellpadding="0" cellspacing="0">
		  <tr>
		    <td>
<script>


function PopUpOnParentRight ( URL, width, height ) 
{ 
	var parentX = window.screenLeft;
	var parentY = window.screenTop;
	
	var childX = parentX + document.body.clientWidth - ( width / 2 );
	var childY = parentY + document.body.clientHeight - height;
	
	var NewWindow = window.open( URL ,"NewWindow","height="+height+",width="+width+",resizable=yes,left=" + childX + ",top=" + childY + ",screenX=" + childX + ",screenY=" + childY + ",scrollbars=yes"); 
	NewWindow.focus(); 
	
	return	true;
}


</script>

 
	<div id="ArticleContentsWrap">
	
	<div id="ArticleContents">
	
	<table width="100%" border="0" cellpadding="0" cellspacing="0" class="d">
		<tr> 
			<td colspan="2">
				<table width="100%" border="0" cellspacing="0" cellpadding="0">
				<tr> 
					<td height="20">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</td>
					<td height="20">&nbsp;</td>
				</tr>
								<tr class="d"> 
					<td height="20">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</td>
					<td height="20" class="LineMap"><a href="search.php?where=jbrowse">Journal List</a>&nbsp;&gt;&nbsp;<a href="search.php?where=jvolume&id=68&code=0068KJR">Korean J Radiol</a>&nbsp;&gt;&nbsp;<a href="search.php?where=asummary&id=8636&code=0068KJR">v.17(5);&nbsp;Sep-Oct&nbsp;2016</a></td>
				</tr>
								<tr> 
					<td height="10">&nbsp</td>
					<td height="10"></td>
				</tr>
					<tr align="vtop"> 
						<td></td>
						<td>
							<div><span class="article-doctype">Neuroimaging and Head & Neck</span><span class="article-openaccess">&nbsp;<img src="image/oa-icon.gif">&nbsp;Open Access</span></div>
						<BR>						
						<DIV>

							<HR CLASS="article-doctype-openaccess-underbar">
							
							<div id="ArticleContentsTopIconBar">	
								<span>							
								<span align="left">
								<a href="search.php?where=aview&id=10.3348/kjr.2016.17.5.620&code=0068KJR&vmode=AONLY"><img src="image/abstract-off.jpg" border="0" align="absmiddle"></a>								<a href="search.php?where=aview&id=10.3348/kjr.2016.17.5.620&code=0068KJR&vmode=FULL"><img src="image/article-on.jpg" border="0" align="absmiddle"></a>								
																	<a href="Synapse/Data/PDFData/0068KJR/kjr-17-620.pdf"><img src="image/pdf-off.jpg" border="0" align="absmiddle"></a>
																<a href="search.php?where=aview&id=10.3348/kjr.2016.17.5.620&code=0068KJR&vmode=PUBREADER"><img src="image/pubreader-on.jpg" border="0" align="absmiddle"></a>
								<a href="epub/10.3348/kjr.2016.17.5.620"><img src="image/epub-on.jpg" border="0" align="absmiddle"></a>
								<a href="search.php?where=aview&id=10.3348/kjr.2016.17.5.620&code=0068KJR&vmode=FT"><img src="image/figtbl-off.jpg" border="0" align="absmiddle"></a>								<a href="search.php?where=aview&id=10.3348/kjr.2016.17.5.620&code=0068KJR&vmode=REF"><img src="image/reference-off.jpg" border="0" align="absmiddle"></a>						
																</span>
								
								<span style="float:right;">
								<A HREF="ShareContents.php?where=aview&type=email&id=10.3348/kjr.2016.17.5.620&code=0068KJR" onClick="javascript:PopUpOnParentRight( this.href, 750, 500 ); return false;"><IMG title="Email this article" SRC="image/icon-email-14.gif" border="0" align="absmiddle" style="margin-left:0px;"></A>
								<A HREF="ShareContents.php?where=aview&type=tw&id=10.3348/kjr.2016.17.5.620" onClick="javascript:PopUpOnParentRight( this.href, 600, 500 ); return false;"><IMG title="Tweet this!" SRC="image/icon-twitter-14.gif" border="0" align="absmiddle" style="margin-left:-3px;"></A>
								<A HREF="ShareContents.php?where=aview&type=fb&id=10.3348/kjr.2016.17.5.620" onClick="javascript:PopUpOnParentRight( this.href, 800, 500 ); return false;"><IMG title="Add to Facebook"  SRC="image/icon-facebook-14.gif" border="0" align="absmiddle" style="margin-left:-3px;"></A>
								<a href="DownloadCitation.php?id=553103&code=0068KJR" onClick="javascript:PopUpOnParentRight( this.href, 750, 450); return false;"><img title="Download Citation" src="image/citation-on.jpg" border="0" align="absmiddle" style="margin-left:-3px;"></a>
								</span>
								
								</span>
										
							</div>
														
							<HR CLASS="article-menubar-bottom">
							
						</DIV>
												
						</td>
					</tr>
				<tr>			
					<td></td>
					<td height="12px"></td>	
				</tr>
				<tr>			
					<td></td>
					<td>								
						<TABLE width="100%" cellSpacing=0 cellPadding=0 border=0 class="Journal">
							<TBODY>
							<TR>
								<TD>
									<div class="ArticleContentsArea">
																			
									<!-- MAIN -->										
									<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd">
<link xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" rel="stylesheet" type="text/css" href="ViewNLM_m.css"><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" id="top" name="top"></a>

<div xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" id="article-level-0-front" class="fm">

<table width="100%" class="fm">

<tr>
<td width="50%"></td>
<td></td>
</tr>

<tr><td valign="top" colspan="2">Korean J Radiol. 2016 Sep-Oct;17(5):620-632. English.<br>Published online August 23, 2016.  <a href="https://doi.org/10.3348/kjr.2016.17.5.620">https://doi.org/10.3348/kjr.2016.17.5.620</a>
<br>
</td></tr>
<tr><td colspan="2" height="25" valign="middle">Copyright © 2016 The Korean Society of Radiology

</td></tr>
</table>
<table width="100%" class="fm">
<tr>
<td></td>
<td></td>
</tr>
<tr><td colspan="2" valign="top" align="left"><span class="tl-document"><left><i>In-Vivo</i> Proton Magnetic Resonance Spectroscopy of 2-Hydroxyglutarate in Isocitrate Dehydrogenase-Mutated Gliomas: A Technical Review for Neuroradiologists
</left></span></td></tr>
<tr><td colspan="2" valign="top" align="left">
<span class="capture-id">Hyeonjin Kim, PhD,<sup><IMG src="image/icon_corresp.gif" BORDER="0" valign="TOP"></sup><sup>1</sup><sup>,</sup><sup>2</sup><sup>,</sup><sup>3</sup></span>
<span class="capture-id">Sungjin Kim, MS,<sup>1</sup></span>
<span class="capture-id">Hyeong Hun Lee, BS,<sup>2</sup></span>
 and <span class="capture-id">Hwon Heo, PhD<sup>2</sup></span>
</td></tr>
<tr><td colspan="2" valign="top" align="left">
<sup>1</sup>Department of Radiology, Seoul National University Hospital, Seoul 03080, Korea.<br>
</td></tr>
<tr><td colspan="2" valign="top" align="left">
<sup>2</sup>Department of Biomedical Sciences, Seoul National University, Seoul 03087, Korea.<br>
</td></tr>
<tr><td colspan="2" valign="top" align="left">
<sup>3</sup>Institute of Radiation Medicine, Seoul National University Medical Research Center, Seoul 03080, Korea.<br>
</td></tr>
<tr><td colspan="2" align="left"><div align="left">
<br><span class="capture-id"><span class="gen"></span><sup><IMG src="image/icon_corresp.gif" BORDER="0" valign="TOP"></sup>
Corresponding author: Hyeonjin Kim, PhD, Department of Radiology, Seoul National University Hospital, 101 Daehak-ro, Jongno-gu, Seoul 03080, Korea. Tel: (822) 740-8543, Fax: (822) 743-6385, <span class="author-email">Email: <A href="mailto:hyeonjinkim@snu.ac.kr">hyeonjinkim@snu.ac.kr</A></span>


</span><br>
</div></td></tr>
<tr><td></td></tr>
<tr><td valign="top" align="left" colspan="2" class="fm_small">Received February 03, 2016; Accepted  June 02, 2016.<br><br>
</td></tr>
<tr><td valign="top" align="left" colspan="2" class="fm_small">
<p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<a href="http://creativecommons.org/licenses/by-nc/3.0/" target="_blank">http://creativecommons.org/licenses/by-<wbr/>nc/3.0/</a>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</p>
<br>
</td></tr>
<tr><td valign="top" align="left" colspan="2" class="fm_small"><div class=links-box><font color="#000000"><img src="image/right-arrow.gif" style="vertical-align: middle;">&nbsp;<a href="CitedBy.php?id=553103&code=0068KJR" onClick="javascript:PopUpOnParentRight( this.href, 750, 400 ); return false;">This article has been cited by <strong><font color="#000000">2</font></strong> articles in</font>&nbsp;&nbsp;<img src="image/icon_synapse.gif" border="0" align="absbottom"><img src="image/icon_CrossRef.gif" border="0" align="absbottom"></a><BR><img src="image/right-arrow.gif" style="vertical-align: middle;">&nbsp;<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/27587950/citedby" target="_blank">This article has been cited by <strong><font color="#000000">1</font></strong> article in</font>&nbsp;<font color="#004f8a">PubMed Central</font>.</a><BR><img src="image/right-arrow.gif" style="vertical-align: middle;">&nbsp;<a href="https://scholar.google.com/scholar?cites=http%3A%2F%2Fdx.doi.org%2F10.3348%2Fkjr.2016.17.5.620" target="_blank">This article has been cited by <FONT color=#324eba>G</FONT><FONT color=#e92736>o</FONT><FONT color=#feac06>o</FONT><FONT color=#324eba>g</FONT><FONT color=#0cb225>l</FONT><FONT color=#e92736>e</FONT>&nbsp;<FONT color=#324eba>Scholar</FONT>.</a></div><BR><BR></td></tr>


<tr><td colspan="2" valign="top" class="td-section">
<div class="goto">
<a class="ArticleGotoNagivator" href="#ArticleGotoNagivator" title="Go to other sections in this page" rolde="button" aria-expanded="false">Go to:</a><a class="__SECTION__" id="#__ID_SECTION_Abstract" name="#__ID_SECTION_Abstract"></a><div class="goto_section"></div>
</div>
<div class="tl-main-part">Abstract</div>
</td></tr>
<tr>
<td colspan="2" valign="top">
<br><p>The diagnostic and prognostic potential of an onco-metabolite, 2-hydroxyglutarate (2HG) as a proton magnetic resonance spectroscopy (1H-MRS) detectable biomarker of the isocitrate dehydrogenase (IDH)-mutated (IDH-MT) gliomas has drawn attention of neuroradiologists recently. However, due to severe spectral overlap with background signals, quantification of 2HG can be very challenging. In this technical review for neuroradiologists, first, the biochemistry of 2HG and its significance in the diagnosis of IDH-MT gliomas are summarized. Secondly, various 1H-MRS methods used in the previous studies are outlined. Finally, wereview previous <i>in vivo</i> studies, and discuss the current status of 1H-MRS in the diagnosis of IDH-MT gliomas.</p>
</td>
</tr>
</table>


</div>

<div id="article-level-0-end-metadata" class="fm">
<div class="p"><table width="100%" class="fm">
<tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl">
<td width="30%"></td>
<td></td>
</tr>

<tr>
<td colspan="2" valign="top"><p><b>Keywords: </b><span xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" class="capture-id">Proton</span>; <span xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" class="capture-id">Magnetic resonance spectroscopy</span>; <span xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" class="capture-id">MRS</span>; <span xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" class="capture-id">Isocitrate dehydrogenase</span>; <span xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" class="capture-id">2-hydroxyglutarate</span>; <span xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" class="capture-id">Glioma</span>; <span xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" class="capture-id">Mutation</span></p></td>
</tr>
</table></div>

</div>

<div id="article-level-0-body" class="body">

<div xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl">
<table width="100%"><tr><td class="td-section">
<div class="goto">
<a class="ArticleGotoNagivator" href="#ArticleGotoNagivator" title="Go to other sections in this page" rolde="button" aria-expanded="false">Go to:</a><a class="__SECTION__" id="#__ID_SECTION_INTRODUCTION" name="#__ID_SECTION_INTRODUCTION"></a><div class="goto_section"></div>
</div>
<div class="tl-main-part">INTRODUCTION</div>
</td></tr></table>

<p>Proton magnetic resonance spectroscopy (1H-MRS) has traditionally been used in the metabolic research of gliomas and its diagnostic value is well explored (<span class="xref"><a href="#B1">1</a></span><span class="xref"><span class="gen">, </span><a href="#B2">2</a></span><span class="xref"><span class="gen">, </span><a href="#B3">3</a></span><span class="xref"><span class="gen">, </span><a href="#B4">4</a></span><span class="xref"><span class="gen">, </span><a href="#B5">5</a></span><span class="xref"><span class="gen">, </span><a href="#B6">6</a></span><span class="xref"><span class="gen">, </span><a href="#B7">7</a></span><span class="xref"><span class="gen">, </span><a href="#B8">8</a></span><span class="xref"><span class="gen">, </span><a href="#B9">9</a></span>). Currently, however, 1H-MRS is used only as a supplemental tool to magnetic resonance imaging (MRI) in the diagnosis of gliomas (<span class="xref"><a href="#B2">2</a></span><span class="xref"><span class="gen">, </span><a href="#B5">5</a></span><span class="xref"><span class="gen">, </span><a href="#B9">9</a></span>). Such limited application of 1H-MRS in the diagnosis of gliomas can be attributed to the intrinsic low concentrations of metabolites and the limited spectral signal-to-noise ratio (SNR) and dispersion at clinical field strength. In addition, lack of specificity of metabolites that are previously proposed as biomarkers of gliomas is also responsible for its low demand by neuroradiologists. In this regard, the emergence of 2-hydroxyglutarate (2HG) as an onco-metabolite overproduced in isocitrate dehydrogenase (IDH)-mutated (IDH-MT) gliomas (<span class="xref"><a href="#B10">10</a></span><span class="xref"><span class="gen">, </span><a href="#B11">11</a></span><span class="xref"><span class="gen">, </span><a href="#B12">12</a></span><span class="xref"><span class="gen">, </span><a href="#B13">13</a></span>), the substantially longer survival duration of IDH-MT glioma patients relative to those with IDH wild-type (IDH-WT) gliomas (<span class="xref"><a href="#B11">11</a></span>), and recent pioneering studies on the feasibility of non-invasive detection of 2HG by 1H-MRS (<span class="xref"><a href="#B14">14</a></span><span class="xref"><span class="gen">, </span><a href="#B15">15</a></span><span class="xref"><span class="gen">, </span><a href="#B16">16</a></span>), collectively, have recently drawn attention of neuroradiologists. However, due to severe spectral overlap with its background signal, the quantification of 2HG is reportedly challenging (<span class="xref"><a href="#B15">15</a></span><span class="xref"><span class="gen">, </span><a href="#B16">16</a></span>). As such, despite a total of only 9 studies reported to date (<span class="xref"><a href="#B14">14</a></span><span class="xref"><span class="gen">, </span><a href="#B15">15</a></span><span class="xref"><span class="gen">, </span><a href="#B16">16</a></span><span class="xref"><span class="gen">, </span><a href="#B17">17</a></span><span class="xref"><span class="gen">, </span><a href="#B18">18</a></span><span class="xref"><span class="gen">, </span><a href="#B19">19</a></span><span class="xref"><span class="gen">, </span><a href="#B20">20</a></span><span class="xref"><span class="gen">, </span><a href="#B21">21</a></span><span class="xref"><span class="gen">, </span><a href="#B22">22</a></span>) on <i>in-vivo</i> 1H-MRS of 2HG in gliomas including 2 animal studies (<span class="xref"><a href="#B20">20</a></span><span class="xref"><span class="gen">, </span><a href="#B22">22</a></span>), 5 different 1H-MRS methods were already explored.</p>
<p>In this review, we first summarize the biochemistry of 2HG and its significance in the diagnosis of IDH-MT gliomas. Secondly, we comparatively review 1H-MRS methods and findings in the previous studies. Finally, we discuss the current status of 1H-MRS in the diagnosis of IDH-MT gliomas as a technical guideline for neuroradiologists.</p>
</div>

<div xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl">
<table width="100%"><tr><td class="td-section">
<div class="goto">
<a class="ArticleGotoNagivator" href="#ArticleGotoNagivator" title="Go to other sections in this page" rolde="button" aria-expanded="false">Go to:</a><a class="__SECTION__" id="#__ID_SECTION_Altered Metabolism and Overproduction of 2HG in IDH-MT Gliomas and Their Significance in Noninvasive Detection of 2HG by 1H-MRS" name="#__ID_SECTION_Altered%20Metabolism%20and%20Overproduction%20of%202HG%20in%20IDH-MT%20Gliomas%20and%20Their%20Significance%20in%20Noninvasive%20Detection%20of%202HG%20by%201H-MRS"></a><div class="goto_section"></div>
</div>
<div class="tl-main-part">Altered Metabolism and Overproduction of 2HG in IDH-MT Gliomas and Their Significance in Noninvasive Detection of 2HG by 1H-MRS</div>
</td></tr></table>

<p>Isocitrate dehydrogenase is an enzyme with three isoforms, i.e., IDH1, IDH2, and IDH3 (<span class="xref"><a href="#B13">13</a></span>). Intra-cellularly, it catalyzes the oxidative decarboxylation of isocitrate to α-ketoglutarate (α-KG) in cytoplasm and peroxisomes (IDH1) and in mitochondria (IDH2 and IDH3) (<span class="fig-table-link"><a href="#F1">Fig. 1</a></span>) (<span class="xref"><a href="#B13">13</a></span><span class="xref"><span class="gen">, </span><a href="#B23">23</a></span>). Highly frequent mutations in IDH1 and IDH2 genes are reported in low grade gliomas and secondary glioblastomas (<span class="xref"><a href="#B10">10</a></span><span class="xref"><span class="gen">, </span><a href="#B11">11</a></span>). These mutations result in altered enzymatic activities of IDH1 and IDH2 such that they catalyze the reduction of α-KG to 2HG (<span class="xref"><a href="#B12">12</a></span>) instead of facilitating the production of the former (<span class="fig-table-link"><a href="#F1">Fig. 1</a></span>). As it is an aberrant product arising from altered metabolism in IDH-MT gliomas, 2HG is designated as an onco-metabolite (<span class="xref"><a href="#B13">13</a></span><span class="xref"><span class="gen">, </span><a href="#B24">24</a></span>).<div class="image-at-section"><div class="bm" id="F1">
<table width="95%" border="1" cellpadding="10" cellspacing="0" align="center"><tr><td><table width="100%" class="bm">
<tr>
<td width="30%"></td>
<td></td>
</tr>
<tr>
<td valign="top">
<a href="ViewImage.php?Type=F&amp;aid=553103&amp;id=F1&amp;afn=68_KJR_17_5_620&amp;fn=kjr-17-620-g001_0068KJR" target="_blank"><img border="1" src="/ArticleImage/0068KJR/kjr-17-620-g001.jpg"></a>
<br>
</td>
<td valign="top">
<span class="label"><a href="ViewImage.php?Type=F&amp;aid=553103&amp;id=F1&amp;afn=68_KJR_17_5_620&amp;fn=_0068KJR" target="_blank">Fig. 1</a>
</span><span class="capture-id"><br><span class="capture-id">Simplified metabolic pathways associated with isocitrate dehydrogenase (IDH) and 2-hydroxyglutarate (2HG).</span><br><span class="capture-id">Mutations of IDH1 and IDH2 result in overproduction of 2HG. 1H-MRS-visible metabolites including 2HG are marked in bold. Acetyl-CoA = acetyl coenzyme A, Gln = glutamine, Glu = glutamate, GSH = glutathione, GSSG = glutathione disulfide, H<sub>2</sub>O = water, H<sub>2</sub>O<sub>2</sub> = hydrogen peroxide, IDH-MT = mutant isocitrate dehydrogenase, NAD = nicotinamide adenine dinucleotide, NADH = nicotinamide adenine dinucleotide hydrate, NADP = nicotinamide adenine dinucleotide phosphate, NADPH = nicotinamide adenine dinucleotide phosphate hydrate, α-KG = alpha-ketoglutarate</span></span>
</td>
</tr>
<tr>
<td></td>
<td align="left"><span class="ExternalLinkFT"><span><img style="border:0; height:100%; vertical-align: top; margin-right:0.15em;" src="image/icon-f.png"><a href="ViewImage.php?Type=F&amp;aid=553103&amp;id=F1&amp;afn=68_KJR_17_5_620&amp;fn=kjr-17-620-g001_0068KJR" target="_blank">Click for larger image</a></span><span style="margin-left:0.7em;"><img style="border:0; height:100%; vertical-align: top; margin-right:0.15em;" src="image/icon-ppt.png"><a href="ViewImage.php?Type=FP&amp;aid=553103&amp;id=F1&amp;afn=68_KJR_17_5_620&amp;fn=kjr-17-620-g001_0068KJR" target="_blank">Download as PowerPoint slide</a></span></span></td>
</tr>
</table></td></tr></table>
<br>
</div></div><div class="image-at-section"></div></p>
<p>In IDH-MT gliomas, 2HG accumulates to a similar or higher level than 1H-MRS-visible brain metabolites, and 2–3 orders of magnitude higher than in IDH-WT gliomas or normal brain tissue (<span class="xref"><a href="#B13">13</a></span>). Thus, 1H-MRS has the potential to quantify 2HG non-invasively and discriminate IDH-MT gliomas from IDH-WT gliomas as well as normal tissue. Thus, 1H-MRS can directly determine the mutational status of gliomas non-invasively. The substantial difference in the frequency of IDH-mutational status between primary and secondary glioblastomas (<span class="xref"><a href="#B11">11</a></span>) further contributes to the potential diagnostic efficacy of 1H-MRS of 2HG (<span class="xref"><a href="#B24">24</a></span>). In cases where 2HG content correlates with tumor cellularity, 1H-MRS of 2HG can be used for guiding biopsy and surgery (<span class="xref"><a href="#B15">15</a></span><span class="xref"><span class="gen">, </span><a href="#B18">18</a></span>), and monitoring treatment response (<span class="xref"><a href="#B16">16</a></span>). In addition, the longer survival duration of patients with IDH-MT gliomas than IDH-WT gliomas (<span class="xref"><a href="#B11">11</a></span>) also suggests a potential prognostic value of 1H-MRS of 2HG. These characteristics distinguish 2HG from previously proposed brain metabolites as 1H-MRS-etectable biomarkers of gliomas (<span class="xref"><a href="#B1">1</a></span><span class="xref"><span class="gen">, </span><a href="#B2">2</a></span><span class="xref"><span class="gen">, </span><a href="#B6">6</a></span>).</p>
<p>Recent findings also emphasize the potential importance of other brain metabolites in IDH-MT gliomas. For instance, the carbon source of 2HG is derived from glutamine (Gln) (<span class="xref"><a href="#B12">12</a></span>), and the reduction of glutamate (Glu) levels may be associated with the pathogenesis of the IDH1-MT gliomas (<span class="xref"><a href="#B25">25</a></span><span class="xref"><span class="gen">, </span><a href="#B26">26</a></span>). Also, the down-regulation of glutathione (GSH) in IDH1-MT gliomas is proposed as a potential therapeutic target (<span class="xref"><a href="#B27">27</a></span>). Therefore, developing 1H-MRS methods that allow for more comprehensive metabolic profiling can play a pivotal role for better understanding the pathogenesis and progression of the diseases such as whether the oncogenesis is directly associated with 2HG or a consequence of the subsequent metabolic alterations. It may also shed light on the underlying mechanism of longer survival of patients with IDH-MT glioma vs. IDH-WT gliomas (<span class="xref"><a href="#B20">20</a></span><span class="xref"><span class="gen">, </span><a href="#B25">25</a></span><span class="xref"><span class="gen">, </span><a href="#B26">26</a></span><span class="xref"><span class="gen">, </span><a href="#B27">27</a></span>), and the development of novel therapeutic strategies (<span class="xref"><a href="#B26">26</a></span><span class="xref"><span class="gen">, </span><a href="#B27">27</a></span><span class="xref"><span class="gen">, </span><a href="#B28">28</a></span>).</p>
</div>

<div xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl">
<table width="100%"><tr><td class="td-section">
<div class="goto">
<a class="ArticleGotoNagivator" href="#ArticleGotoNagivator" title="Go to other sections in this page" rolde="button" aria-expanded="false">Go to:</a><a class="__SECTION__" id="#__ID_SECTION_Spectral Characteristics of 2HG and Its Background Metabolites" name="#__ID_SECTION_Spectral%20Characteristics%20of%202HG%20and%20Its%20Background%20Metabolites"></a><div class="goto_section"></div>
</div>
<div class="tl-main-part">Spectral Characteristics of 2HG and Its Background Metabolites</div>
</td></tr></table>

<p>The 2HG molecule has 5 non-exchangeable protons (5-spin system) with complicated J-coupling interactions (<span class="xref"><a href="#B16">16</a></span>). These interactions refer to inter-spin interactions through electron bonds in a molecule (<span class="xref"><a href="#B29">29</a></span><span class="xref"><span class="gen">, </span><a href="#B30">30</a></span>). Such an indirect interaction between spins rather than a direct interaction through space is termed as J-coupling and the spins involved in the interaction are said to be J-coupled (<span class="xref"><a href="#B29">29</a></span><span class="xref"><span class="gen">, </span><a href="#B30">30</a></span>). J-coupling results in peak splitting (e.g., a singlet into a multiplet) and changes in line shape and signal amplitude as a function of time (typically, echo time [TE]), namely J-evolution (<span class="xref"><a href="#B29">29</a></span><span class="xref"><span class="gen">, </span><a href="#B30">30</a></span>). Different spin systems undergo different J-evolution depending on their coupling networks and coupling strength expressed as a J-constant in Hz (<span class="xref"><a href="#B29">29</a></span><span class="xref"><span class="gen">, </span><a href="#B30">30</a></span>). The majority of the 1H-MRS-detectable metabolites have coupled spins such as 2HG, Glu, Gln, gamma-aminobutylic acid (GABA), and N-acetylaspartylglutamate (NAAG) (<span class="xref"><a href="#B31">31</a></span>). On the other hand, water and creatine (Cr) are representative metabolites with uncoupled spins only. The spectral characteristics of 2HG are determined by J-coupling in combination with the resonance frequencies of the 5 protons that are determined by chemical environments of the protons in the molecule (chemical-shift), giving rise to three multiplets at 3T centered at ~4.0, ~2.3, and ~1.9 ppm (contributed by 1, 2, and 2 spins, respectively) (<span class="fig-table-link"><a href="#F2">Fig. 2</a></span>) (<span class="xref"><a href="#B16">16</a></span>). The spins resonating at ~1.9 ppm are J-coupled with the spin resonating at ~4.0 ppm and also with those resonating at ~2.3 ppm (<span class="xref"><a href="#B16">16</a></span>). The multiplet at ~4.0 ppm is relatively small in amplitude as it is contributed by only one proton, overlaps with signals from lactate (Lac) and myo-inositol (mI) (<span class="fig-table-link"><a href="#F3">Fig. 3</a></span>), and is close to the strong Cr (~3.9 ppm) and water (~4.7 ppm) signals. The multiplet at ~1.9 ppm also overlaps with signals from other metabolites (<span class="fig-table-link"><a href="#F2">Fig. 2</a></span>), in particular, with N-acetylaspartate (NAA) (<span class="fig-table-link"><a href="#F3">Fig. 3</a></span>). The multiplet at ~2.3 ppm has the largest signal and is therefore widely used as a target signal for 2HG quantification (<span class="fig-table-link"><a href="#F2">Fig. 2</a></span>). However, it also severely overlaps with signals from at least 4 other metabolites (<span class="fig-table-link"><a href="#F2">Figs. 2</a></span><span class="gen">, </span><span class="fig-table-link"><a href="#F3">3</a></span>) (<span class="xref"><a href="#B15">15</a></span><span class="xref"><span class="gen">, </span><a href="#B16">16</a></span>).<div class="image-at-section"><div class="bm" id="F2">
<table width="95%" border="1" cellpadding="10" cellspacing="0" align="center"><tr><td><table width="100%" class="bm">
<tr>
<td width="30%"></td>
<td></td>
</tr>
<tr>
<td valign="top">
<a href="ViewImage.php?Type=F&amp;aid=553103&amp;id=F2&amp;afn=68_KJR_17_5_620&amp;fn=kjr-17-620-g002_0068KJR" target="_blank"><img border="1" src="/ArticleImage/0068KJR/kjr-17-620-g002.jpg"></a>
<br>
</td>
<td valign="top">
<span class="label"><a href="ViewImage.php?Type=F&amp;aid=553103&amp;id=F2&amp;afn=68_KJR_17_5_620&amp;fn=_0068KJR" target="_blank">Fig. 2</a>
</span><span class="capture-id"><br><span class="capture-id">Simulated spectra of 2HG and its background metabolites at 3T.</span><br><span class="capture-id">Concentration ratio of 5:9.25:4.5:1.5:1.5 (mM) was assumed for 2HG:Glu:Gln:GABA:NAAG. Linewidth of all spectra were broadened to mimic <i>in-vivo</i> spectra. GABA = gamma-aminobutylic acid, Gln = glutamine, Glu = glutamate, NAAG = N-acetylaspartylglutamate, 2HG = 2-hydroxyglutarate</span></span>
</td>
</tr>
<tr>
<td></td>
<td align="left"><span class="ExternalLinkFT"><span><img style="border:0; height:100%; vertical-align: top; margin-right:0.15em;" src="image/icon-f.png"><a href="ViewImage.php?Type=F&amp;aid=553103&amp;id=F2&amp;afn=68_KJR_17_5_620&amp;fn=kjr-17-620-g002_0068KJR" target="_blank">Click for larger image</a></span><span style="margin-left:0.7em;"><img style="border:0; height:100%; vertical-align: top; margin-right:0.15em;" src="image/icon-ppt.png"><a href="ViewImage.php?Type=FP&amp;aid=553103&amp;id=F2&amp;afn=68_KJR_17_5_620&amp;fn=kjr-17-620-g002_0068KJR" target="_blank">Download as PowerPoint slide</a></span></span></td>
</tr>
</table></td></tr></table>
<br>
</div></div><div class="image-at-section"><div class="bm" id="F3">
<table width="95%" border="1" cellpadding="10" cellspacing="0" align="center"><tr><td><table width="100%" class="bm">
<tr>
<td width="30%"></td>
<td></td>
</tr>
<tr>
<td valign="top">
<a href="ViewImage.php?Type=F&amp;aid=553103&amp;id=F3&amp;afn=68_KJR_17_5_620&amp;fn=kjr-17-620-g003_0068KJR" target="_blank"><img border="1" src="/ArticleImage/0068KJR/kjr-17-620-g003.jpg"></a>
<br>
</td>
<td valign="top">
<span class="label"><a href="ViewImage.php?Type=F&amp;aid=553103&amp;id=F3&amp;afn=68_KJR_17_5_620&amp;fn=_0068KJR" target="_blank">Fig. 3</a>
</span><span class="capture-id"><br><span class="capture-id">Representative <i>in-vivo</i> spectra of normal human brain at 3T acquired at short TE (A) and long TE (B).</span><br><span class="capture-id">Spectral baseline is also illustrated in <b>A</b>, which is typically assumed to be negligible in <b>B</b>. In <b>B</b>, spectrum consists mainly of Cr (~3.0 and ~3.9 ppm), Cho (~3.2 ppm), and NAA (~2.0 ppm) signals. Spectral locations of 2HG are also shown. Asp = aspartate, Cho = choline, Cr = creatine, GABA = gamma-aminobutylic acid, Gln = glutamine, Glu = glutamate, Gly = glycine, Lac = lactate, mI = myo-inositol, NAA = N-acetylaspartate, NAAG = N-acetylaspartylglutamate, Tau = taurine, TE = echo time, 2HG = 2-hydroxyglutarate</span></span>
</td>
</tr>
<tr>
<td></td>
<td align="left"><span class="ExternalLinkFT"><span><img style="border:0; height:100%; vertical-align: top; margin-right:0.15em;" src="image/icon-f.png"><a href="ViewImage.php?Type=F&amp;aid=553103&amp;id=F3&amp;afn=68_KJR_17_5_620&amp;fn=kjr-17-620-g003_0068KJR" target="_blank">Click for larger image</a></span><span style="margin-left:0.7em;"><img style="border:0; height:100%; vertical-align: top; margin-right:0.15em;" src="image/icon-ppt.png"><a href="ViewImage.php?Type=FP&amp;aid=553103&amp;id=F3&amp;afn=68_KJR_17_5_620&amp;fn=kjr-17-620-g003_0068KJR" target="_blank">Download as PowerPoint slide</a></span></span></td>
</tr>
</table></td></tr></table>
<br>
</div></div><div class="image-at-section"></div><div class="image-at-section"></div><div class="image-at-section"></div><div class="image-at-section"></div><div class="image-at-section"></div></p>
</div>

<div xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl">
<table width="100%"><tr><td class="td-section">
<div class="goto">
<a class="ArticleGotoNagivator" href="#ArticleGotoNagivator" title="Go to other sections in this page" rolde="button" aria-expanded="false">Go to:</a><a class="__SECTION__" id="#__ID_SECTION_Short TE, Long TE, Difference Editing and 2D Methods, and Data Post-Processing" name="#__ID_SECTION_Short%20TE,%20Long%20TE,%20Difference%20Editing%20and%202D%20Methods,%20and%20Data%20Post-Processing"></a><div class="goto_section"></div>
</div>
<div class="tl-main-part">Short TE, Long TE, Difference Editing and 2D Methods, and Data Post-Processing</div>
</td></tr></table>

<div>
<p class="tl-lowest-section">Short TE</p>
<p>In a short TE method, spectra are acquired at a shortest TE attainable in order to minimize signal loss resulting from relaxation and, for coupled spins, J-evolution. For a PRESS sequence (<span class="xref"><a href="#B32">32</a></span>) that is one of the most widely used single-voxel 1H-MRS pulse sequences together with a STEAM sequence (<span class="xref"><a href="#B33">33</a></span>) at clinical field strength, a shortest TE can slightly differ for different MR scanners depending on the design of radio-frequency (RF) and gradient pulses, but is ~30 ms at 3T. At a shortest TE, all metabolite signals are maximized, which is of great advantage in terms of SNR of spectra and thus scan time. A short TE method does not require any modification of vendor-provided pulse sequences, hence is most commonly used in 1H-MRS in combination with spectral fitting for quantification of individual metabolites.</p>
<p>However, a shortest TE maximizes not only the target signal of 2HG at ~2.3 ppm but also those background signals from Glu, Gln, GABA, and NAAG (<span class="fig-table-link"><a href="#F2">Fig. 2</a></span>). The resulting severe spectral overlap is exacerbated by the presence of spectral baseline that is also maximized at the shortest TE (<span class="fig-table-link"><a href="#F3">Fig. 3</a></span>). Spectral baseline is contributed mainly by macromolecules (MMs) such as proteins and peptides (<span class="xref"><a href="#B34">34</a></span>), and also by lipid (<span class="xref"><a href="#B35">35</a></span><span class="xref"><span class="gen">, </span><a href="#B36">36</a></span>). MMs also have J-coupled spins and their T1 and T2 are short relative to metabolites (<span class="xref"><a href="#B34">34</a></span>). The influence of spectral baseline on the quantitative analysis of spectra acquired at a shortest TE is well documented (<span class="xref"><a href="#B37">37</a></span><span class="xref"><span class="gen">, </span><a href="#B38">38</a></span>). In particular, quantification of Glu and Gln is most influenced by spectral baseline among the 1H-MRS-visible metabolites (<span class="xref"><a href="#B37">37</a></span>). As the target signal of 2HG at ~2.3 ppm directly overlaps with Glu and Gln, the quantification of 2HG by using a short TE method can be very challenging, sometimes resulting in false 2HG-positive or 2HG-negative cases, as previously demonstrated (<span class="xref"><a href="#B14">14</a></span><span class="xref"><span class="gen">, </span><a href="#B15">15</a></span><span class="xref"><span class="gen">, </span><a href="#B17">17</a></span>). For this reason, different 1H-MRS methods were explored in the previous 1H-MRS 2HG studies such as a long TE method (<span class="xref"><a href="#B16">16</a></span><span class="xref"><span class="gen">, </span><a href="#B17">17</a></span><span class="xref"><span class="gen">, </span><a href="#B19">19</a></span><span class="xref"><span class="gen">, </span><a href="#B21">21</a></span>), a difference editing (<span class="xref"><a href="#B15">15</a></span><span class="xref"><span class="gen">, </span><a href="#B16">16</a></span>), and a 2-dimensional (2D) method (<span class="xref"><a href="#B15">15</a></span>).<div class="image-at-section"></div><div class="image-at-section"></div></p>
<p>To minimize its influence on the quantitative outcome, spectral baseline can be modeled based on metabolite-nulled spectra as a surrogate of true spectral baseline, which are acquired with T1-weighting by taking advantage of the substantially short T1 of MMs relative to those of metabolites (<span class="xref"><a href="#B35">35</a></span><span class="xref"><span class="gen">, </span><a href="#B37">37</a></span>). The modeled spectral baseline is then incorporated into the spectral fitting. A better but more time-consuming approach is to acquire such a metabolite-nulled spectrum in a subject-specific manner (<span class="xref"><a href="#B39">39</a></span><span class="xref"><span class="gen">, </span><a href="#B40">40</a></span>).</p>
</div>
<div>
<p class="tl-lowest-section">Long TE</p>
<p>A long TE method, which is a simplest practice of 'spectral editing', takes advantage of different J-evolution of different coupled spin systems (<span class="xref"><a href="#B30">30</a></span><span class="xref"><span class="gen">, </span><a href="#B41">41</a></span>). It also takes advantage of different T2 between metabolites and spectral baseline (<span class="xref"><a href="#B41">41</a></span>). Using J-evolution and T2 as 'spectral contrast', spectra can be 'edited' for discriminating a target signal from background signals, and the integrity of the edited target signal is determined by how precisely the long TE is tuned.</p>
<p>In fact, a long TE method has long been used for 1H-MRS of gliomas, for instance, for the quantification of Cr and choline (Cho) (<span class="fig-table-link"><a href="#F3">Fig. 3</a></span>) (<span class="xref"><a href="#B7">7</a></span>). A long TE does not need to be fine-tuned for such singlets from uncoupled spins. It is simply optimized by making it as long as possible such that spectral baseline and background metabolite signals from coupled spins are effectively suppressed, while retaining an observable amount of signal from the target singlet(s) (<span class="fig-table-link"><a href="#F3">Fig. 3</a></span>). However, for spectral editing of a target metabolite with coupled spins against background metabolites also with coupled spins, thorough analyses of the evolution of all spin systems involved are required for optimization of TE (<span class="xref"><a href="#B41">41</a></span><span class="xref"><span class="gen">, </span><a href="#B42">42</a></span>). For a simple coupled spin system, this can be achieved by analytically calculating the spin evolution using product operators (<span class="xref"><a href="#B43">43</a></span>) assuming that all RF pulses are applied instantaneously (<span class="xref"><a href="#B29">29</a></span><span class="xref"><span class="gen">, </span><a href="#B43">43</a></span>). For instance, for the Lac spin system, the J-evolution of the doublet at ~1.3 ppm can be approximated simply with a cos (π·J·TE) term, where J is the J-constant between the coupled spins (=6.93 Hz for Lac) (<span class="xref"><a href="#B29">29</a></span>). However, for more complicated spin systems such as 2HG, Glu, and Gln, analytic solution of spin evolution is difficult and requires numerical calculation (<span class="xref"><a href="#B42">42</a></span><span class="xref"><span class="gen">, </span><a href="#B44">44</a></span><span class="xref"><span class="gen">, </span><a href="#B45">45</a></span>) or investigation at least in phantom. This approach can also incorporate the intra-pulse spin evolution particularly during slice selection (<span class="xref"><a href="#B42">42</a></span><span class="xref"><span class="gen">, </span><a href="#B44">44</a></span><span class="xref"><span class="gen">, </span><a href="#B45">45</a></span>). The signal yield of coupled spins can substantially differ for different combinations of TE1 and TE2 for a given total TE (= TE1 + TE2) with a PRESS sequence (<span class="xref"><a href="#B41">41</a></span><span class="xref"><span class="gen">, </span><a href="#B46">46</a></span>). Also, to minimize the signal loss of a target signal and maximize the suppression of spectral baseline, an optimal total TE is chosen as ≥ ~100 ms at 3T (<span class="xref"><a href="#B16">16</a></span><span class="xref"><span class="gen">, </span><a href="#B19">19</a></span><span class="xref"><span class="gen">, </span><a href="#B41">41</a></span>). Optimal TE facilitates great improvement of the signal-to-background ratio of a target signal at the cost of its SNR, which is the primary purpose of spectral editing (<span class="xref"><a href="#B41">41</a></span>).<div class="image-at-section"></div><div class="image-at-section"></div></p>
<p>While a long TE method may provide an effectively isolated target signal, it is subject to quantitative error due to T2 relaxation, which may be altered in the diseased brain or in the progression of diseases (<span class="xref"><a href="#B21">21</a></span><span class="xref"><span class="gen">, </span><a href="#B47">47</a></span>). Also, a long TE method with a PRESS sequence may require pulse sequence modification for individually adjustable TE1 and TE2.</p>
</div>
<div>
<p class="tl-lowest-section">Difference Editing</p>
<p>A difference editing method utilizes J-coupling as spectral contrast as in the long TE method, and has long been used in glioma for Lac editing against lipid that also has the major signal at ~1.3 ppm (<span class="xref"><a href="#B48">48</a></span>). Recalling that the J-evolution of the Lac doublet at ~1.3 ppm can be approximated by cos (π·J·TE) with J = 6.93 Hz, the Lac signal is inverted at TE = 1/J = 144 ms (because cos (π) = -1), and evolves back to positive signal at TE = 2/J = 288 ms (because cos (2π) = 1) (<span class="xref"><a href="#B48">48</a></span>). By subtracting the former from the latter, the target spectral region of the resulting 'difference' spectrum is contributed mainly by Lac (<span class="xref"><a href="#B48">48</a></span>). Alternative to this approach using two different TEs, frequency-selective RF pulses (a pair of editing pulses) can be used for difference editing, often with a set of spoiling gradient pulses (<span class="xref"><a href="#B49">49</a></span><span class="xref"><span class="gen">, </span><a href="#B50">50</a></span><span class="xref"><span class="gen">, </span><a href="#B51">51</a></span>). In the case of 2HG (<span class="xref"><a href="#B15">15</a></span><span class="xref"><span class="gen">, </span><a href="#B16">16</a></span>), the editing pulses are tuned at ~1.9 ppm, and yet indirectly influence the line shape of the multiplet at ~4.0 ppm due to J-coupling between the spins contributing to the two multiplets (<span class="fig-table-link"><a href="#F4">Fig. 4</a></span>). By subtracting the two spectra acquired at the same TE but with and without the editing pulses from each other, the target spectral region (~4.0 ppm) in the difference spectrum consists mainly of the signal from 2HG (<span class="fig-table-link"><a href="#F4">Fig. 4</a></span>). Note that although the 2HG signal at ~4.0 ppm has spectral overlap with Lac and mI, those Lac and mI spins responsible for the signals at this target spectral region do not have their J-coupled counterpart spins resonating in the vicinity of ~1.9 ppm (<span class="xref"><a href="#B15">15</a></span><span class="xref"><span class="gen">, </span><a href="#B16">16</a></span>). Therefore, their signals at the target spectral region are canceled out by subtraction.<div class="image-at-section"><div class="bm" id="F4">
<table width="95%" border="1" cellpadding="10" cellspacing="0" align="center"><tr><td><table width="100%" class="bm">
<tr>
<td width="30%"></td>
<td></td>
</tr>
<tr>
<td valign="top">
<a href="ViewImage.php?Type=F&amp;aid=553103&amp;id=F4&amp;afn=68_KJR_17_5_620&amp;fn=kjr-17-620-g004_0068KJR" target="_blank"><img border="1" src="/ArticleImage/0068KJR/kjr-17-620-g004.jpg"></a>
<br>
</td>
<td valign="top">
<span class="label"><a href="ViewImage.php?Type=F&amp;aid=553103&amp;id=F4&amp;afn=68_KJR_17_5_620&amp;fn=_0068KJR" target="_blank">Fig. 4</a>
</span><span class="capture-id"><br><span class="capture-id">Illustration of basic principle of difference editing method for 2HG editing in phantom at 3T.</span><br><span class="capture-id">Spectra acquired with and without editing pulses that are tuned at ~1.9 ppm are shown in red and blue, respectively. By subtracting latter from former, edited 2HG signal is obtained at ~4.0 ppm in difference spectrum (shown in inset), which appears as doublet. Note that peak-to-peak distance of edited 2HG doublet is ~10 Hz at 3T. 2HG = 2-hydroxyglutarate</span></span>
</td>
</tr>
<tr>
<td></td>
<td align="left"><span class="ExternalLinkFT"><span><img style="border:0; height:100%; vertical-align: top; margin-right:0.15em;" src="image/icon-f.png"><a href="ViewImage.php?Type=F&amp;aid=553103&amp;id=F4&amp;afn=68_KJR_17_5_620&amp;fn=kjr-17-620-g004_0068KJR" target="_blank">Click for larger image</a></span><span style="margin-left:0.7em;"><img style="border:0; height:100%; vertical-align: top; margin-right:0.15em;" src="image/icon-ppt.png"><a href="ViewImage.php?Type=FP&amp;aid=553103&amp;id=F4&amp;afn=68_KJR_17_5_620&amp;fn=kjr-17-620-g004_0068KJR" target="_blank">Download as PowerPoint slide</a></span></span></td>
</tr>
</table></td></tr></table>
<br>
</div></div><div class="image-at-section"></div></p>
<p>In difference editing, the pulse sequence optimization requires finding a TE that can yield a maximum signal after subtraction. In the case of using editing pulses, the choice of a TE is subject to the duration of the editing pulses, which are much longer than those pulses for spatial localization to achieve high spectral selectivity (<span class="xref"><a href="#B15">15</a></span><span class="xref"><span class="gen">, </span><a href="#B16">16</a></span>). As such, the total TE is also indispensably long, which may therefore be subject to quantification errors inherent to long TE method. The difference spectra cannot provide comprehensive metabolic profiles. However, the spectrum acquired without the editing pulses may be used instead. As it requires subtraction of spectra with a relatively long scan time, all difference spectra methods are particularly subject to patient motion (<span class="xref"><a href="#B29">29</a></span>). For 2HG, the subtracted 2HG signal at ~4.0 ppm appears a doublet (<span class="fig-table-link"><a href="#F4">Fig. 4</a></span>), and the peak-to-peak distance of the doublet is very useful for examining the integrity of the edited 2HG signal. This is particularly so, given the spectral proximity of the target signal of 2HG to the strong water signal. A basic pulse sequence for difference editing is available commercially. For instance, in Siemens, a generic PRESS sequence can be used in combination with a MEGA module (<span class="xref"><a href="#B49">49</a></span>) implemented in the sequence for additional suppression of water and lipid. The frequency of the editing pulses needs to be adjusted accordingly, and for optimization of TE1 and TE2 separately it may also require sequence modification as with a long TE PRESS sequence.<div class="image-at-section"></div></p>
</div>
<div>
<p class="tl-lowest-section">2D</p>
<p>Two-dimensional methods are in use for high resolution nuclear magnetic resonance to identify the J-coupling network of spin systems (peak assignment) (<span class="xref"><a href="#B52">52</a></span>). The extension of the dimension of spectra is achieved by two time variables in the sequence-one for the time between the excitation and the onset of data acquisition (t<sub>1</sub>) and the other for the duration of data acquisition period (t<sub>2</sub>). For instance, in the correlation spectroscopy (<span class="xref"><a href="#B52">52</a></span><span class="xref"><span class="gen">, </span><a href="#B53">53</a></span>), signal is acquired during the t<sub>2</sub> period as in one-dimensional spectroscopy, but repetitively with different t<sub>1</sub> values. The resulting spectra are expressed on a 2D frequency space (f<sub>1</sub>, f<sub>2</sub>) via the 2D fast Fourier transformation of the signal, S (t<sub>1</sub>, t<sub>2</sub>). The resolution of the spectra is determined not only by the number of data points during t<sub>2</sub> period, but also by the number of experiments with different t<sub>1</sub> values. Among the peaks in the diagonal (f<sub>1</sub> = f<sub>2</sub>) and off-diagonal regions of the spectra, those off-diagonal peaks or cross-peaks provide information on correlations (J-coupling) between peaks, and therefore allow for unambiguous assignment of peaks (<span class="xref"><a href="#B53">53</a></span>). However, due to the long acquisition time required to obtain reasonable spectral resolution, the <i>in-vivo</i> application of 2D-MRS is limited only when a target spectral region is severely crowded with background signals as in the case with 2HG (<span class="xref"><a href="#B15">15</a></span>). Also, a 2D pulse sequence is usually unavailable in clinical scanners, and the method requires additional data post-processing for metabolite quantification (<span class="xref"><a href="#B15">15</a></span>).</p>
<p>Finally, optimal sequence parameters (e.g., TE) can differ for different designs of RF and gradient pulses, and at different field strength. Therefore, sequence optimization needs to be performed for the given MR scanner and pulse sequence.</p>
</div>
<div>
<p class="tl-lowest-section">Data Post-Processing</p>
<p>The LCModel (<span class="xref"><a href="#B38">38</a></span><span class="xref"><span class="gen">, </span><a href="#B54">54</a></span>) is currently the most widely used 1H-MRS data post-processing software package, which performs spectral fitting in frequency-domain. The current version of LCModel employs an extended spectral basis set including modeled MMs and lipids (<span class="xref"><a href="#B35">35</a></span><span class="xref"><span class="gen">, </span><a href="#B36">36</a></span><span class="xref"><span class="gen">, </span><a href="#B54">54</a></span><span class="xref"><span class="gen">, </span><a href="#B55">55</a></span>), and therefore does not require a priori knowledge about spectral baseline. The MRUI (<span class="xref"><a href="#B56">56</a></span>) is another frequently used software package for metabolite quantification, which employs time-domain analysis. In general, one of such software packages is necessary for metabolite quantification for spectra obtained by a short TE method. For those edited spectra, spectral fitting may not be necessary if the target signal is effectively isolated from its background signals. The precision of spectral fitting is typically reported for individual metabolites in terms of the Cramer-Rao-Lower-Bound (CRLB) that sets a lower bound on the variance of the fitting estimate (<span class="xref"><a href="#B44">44</a></span><span class="xref"><span class="gen">, </span><a href="#B57">57</a></span>). A CRLB of ≤ 20% is often used to indicate successful fitting (<span class="xref"><a href="#B11">11</a></span><span class="xref"><span class="gen">, </span><a href="#B12">12</a></span><span class="xref"><span class="gen">, </span><a href="#B15">15</a></span><span class="xref"><span class="gen">, </span><a href="#B22">22</a></span><span class="xref"><span class="gen">, </span><a href="#B29">29</a></span>).</p>
<p>The representative spectra from IDH-WT and IDH-MT glioma patients obtained by short TE and long TE methods are shown in <span class="fig-table-link"><a href="#F5">Figure 5</a></span>, for which LCModel was used for data post-processing.<div class="image-at-section"><div class="bm" id="F5">
<table width="95%" border="1" cellpadding="10" cellspacing="0" align="center"><tr><td><table width="100%" class="bm">
<tr>
<td width="30%"></td>
<td></td>
</tr>
<tr>
<td valign="top">
<a href="ViewImage.php?Type=F&amp;aid=553103&amp;id=F5&amp;afn=68_KJR_17_5_620&amp;fn=kjr-17-620-g005_0068KJR" target="_blank"><img border="1" src="/ArticleImage/0068KJR/kjr-17-620-g005.jpg"></a>
<br>
</td>
<td valign="top">
<span class="label"><a href="ViewImage.php?Type=F&amp;aid=553103&amp;id=F5&amp;afn=68_KJR_17_5_620&amp;fn=_0068KJR" target="_blank">Fig. 5</a>
</span><span class="capture-id"><br><span class="capture-id">Representative brain spectra of glioma patients by using short TE and long TE methods at 3T.</span><br><span class="capture-id">Spectra from IDH-MT glioma patient <b>(A, B)</b> are compared with those from IDH-WT glioma patient <b>(C, D)</b>. For all spectra, correct diagnostic results were obtained by LCModel (i.e., 2HG-positive for <b>A</b> and <b>B</b>, and 2HG-negative for <b>C</b> and <b>D</b>). Compared to spectra from normal human brain (<span class="fig-table-link"><a href="#F3">Fig. 3</a></span>), Cho/NAA ratios were substantially increased in these glioma patients. Cho = choline, Cr = creatine, GABA = gamma-aminobutylic acid, Gln = glutamine, Glu = glutamate, IDH-MT = isocitrate dehydrogenase-mutated, IDH-WT = isocitrate dehydrogenase wild-type, Lac = lactate, mI = myo-inositol, NAA = N-acetylaspartate, NAAG = N-acetylaspartylglutamate, TE = echo time, 2HG = 2-hydroxyglutarate</span></span>
</td>
</tr>
<tr>
<td></td>
<td align="left"><span class="ExternalLinkFT"><span><img style="border:0; height:100%; vertical-align: top; margin-right:0.15em;" src="image/icon-f.png"><a href="ViewImage.php?Type=F&amp;aid=553103&amp;id=F5&amp;afn=68_KJR_17_5_620&amp;fn=kjr-17-620-g005_0068KJR" target="_blank">Click for larger image</a></span><span style="margin-left:0.7em;"><img style="border:0; height:100%; vertical-align: top; margin-right:0.15em;" src="image/icon-ppt.png"><a href="ViewImage.php?Type=FP&amp;aid=553103&amp;id=F5&amp;afn=68_KJR_17_5_620&amp;fn=kjr-17-620-g005_0068KJR" target="_blank">Download as PowerPoint slide</a></span></span></td>
</tr>
</table></td></tr></table>
<br>
</div></div></p>
</div>
</div>

<div xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl">
<table width="100%"><tr><td class="td-section">
<div class="goto">
<a class="ArticleGotoNagivator" href="#ArticleGotoNagivator" title="Go to other sections in this page" rolde="button" aria-expanded="false">Go to:</a><a class="__SECTION__" id="#__ID_SECTION_Reviews on In-Vivo 1H-MRS Studies in IDH-MT Gliomas" name="#__ID_SECTION_Reviews%20on%20In-Vivo%201H-MRS%20Studies%20in%20IDH-MT%20Gliomas"></a><div class="goto_section"></div>
</div>
<div class="tl-main-part">Reviews on <i>In-Vivo</i> 1H-MRS Studies in IDH-MT Gliomas</div>
</td></tr></table>

<p>The 1H-MRS methods for identifying IDH-mutational status in gliomas in the previous <i>in-vivo</i> studies are summarized in <span class="fig-table-link"><a href="#T1">Table 1</a></span>.<div class="image-at-section"><div class="bm">
<table width="95%" border="1" cellpadding="10" cellspacing="0" align="center"><tr><td><table width="100%" class="bm">
<tr>
<td width="30%"></td>
<td></td>
</tr>
<tr>
<td valign="top" id="T1">
<a href="ViewImage.php?Type=TH&amp;aid=553103&amp;id=T1&amp;afn=68_KJR_17_5_620&amp;fn=kjr-17-620-i001_0068KJR" target="_blank"><img border="0" src="/ArticleImage/0068KJR/kjr-17-620-i001.jpg"></a>
<br>
</td>
<td valign="top">
<span class="label"><a href="ViewImage.php?Type=T&amp;aid=553103&amp;id=T1&amp;afn=68_KJR_17_5_620&amp;fn=_0068KJR" target="_blank">Table 1</a>
</span><span class="capture-id"><br><span class="capture-id">1H-MRS Methods and Their Performance in Identifying IDH-Mutational Status in Gliomas</span></span>
</td>
</tr>
<tr>
<td></td>
<td align="left"><span class="ExternalLinkFT"><span><img src="image/icon-t.png"><a href="ViewImage.php?Type=T&amp;aid=553103&amp;id=T1&amp;afn=68_KJR_17_5_620&amp;fn=kjr-17-620-i001_0068KJR" target="_blank">Click for larger image</a></span><span style="margin-left:0.7em;"><img src="image/icon-t.png"><a href="ViewImage.php?Type=TH&amp;aid=553103&amp;id=T1&amp;afn=68_KJR_17_5_620&amp;fn=kjr-17-620-i001_0068KJR" target="_blank">Click for full table</a></span><span style="margin-left:0.7em;"><img src="image/icon-excel.png"><a href="ViewImage.php?Type=TX&amp;aid=553103&amp;id=T1&amp;afn=68_KJR_17_5_620&amp;fn=kjr-17-620-i001_0068KJR" target="_blank">Download as Excel file</a></span></span></td>
</tr>
</table></td></tr></table>
<br>
</div></div></p>
<div>
<p class="tl-lowest-section">Short TE</p>
<p>Pope et al. (<span class="xref"><a href="#B14">14</a></span>) report 100% sensitivity and 74% specificity of a short TE method, in 9 IDH-MT and 15 IDH-WT glioma patients with 4 false positive cases. The 2HG concentrations as measured by 1H-MRS and liquid chromatography-mass spectrometry (LC-MS) are highly correlated (r<sup>2</sup> &gt; 0.56); but 2HG concentrations (LC-MS) are not correlated with tumor grades. Andronesi et al. (<span class="xref"><a href="#B15">15</a></span>) compare performance of a short TE method to difference editing and 2D methods; while sensitivity and specificity are not reported, limited performance of a short TE method is shown, wherein 3 spectra from 2 healthy voxels and 1 IDH-WT tumor voxel result in false positive cases (including one case with CRLB &gt; 20% from a healthy subject). Choi et al. (<span class="xref"><a href="#B17">17</a></span>) show a 77% sensitivity and 100% specificity for a short TE method in comparison to a long TE method. In a study on 1H-MRS performance in patients, Natsumeda et al. (<span class="xref"><a href="#B18">18</a></span>) report 100% sensitivity and 72% specificity where a 2HG cutoff concentration of 1.489 mM is used in differentiation between 2HG-positive and -negative cases in consideration of the limited SNR of 1H-MRS. In this study, 10 of 25 data (40%) from IDH-MT glioma patients and 9 of 27 data (33%) from IDH-WT glioma patients are excluded according to the data exclusion criteria based on the resulting 2HG concentrations and respective CRLB values. Interestingly, the survival rate of the IDH-MT glioma patients is significantly higher than the IDH-WT glioma patients (80% vs. 44.4%), corroborating previous reports (<span class="xref"><a href="#B11">11</a></span>); in addition, patients with high 2HG concentrations (&gt; 1.489 mM) show a longer overall survival trend than those with low 2HG concentrations.</p>
<p>The performance of a short TE method is also tested in animal models at high field (<span class="xref"><a href="#B20">20</a></span><span class="xref"><span class="gen">, </span><a href="#B22">22</a></span>). Given the heterogeneity of gliomas in humans, the use of animal models can provide a better comparison between the study cohorts with and without IDH-mutation (<span class="xref"><a href="#B20">20</a></span>). Lazovic et al. (<span class="xref"><a href="#B20">20</a></span>) report 100% sensitivity and specificity at 7T in mouse glioma models using human U87 glioma cells overexpressing IDH1-mutation. Such excellent performance of a short TE method most likely results from higher spectral SNR and dispersion of the spectra at high field, large voxel size and number of signal averages, and high 2HG concentrations (10–20 mM) in the animal models. Additionally, diffusion, perfusion, and T2-weighted (T2-mapping) MRI scans show no significant difference in the respective MRI measures between the animal groups with and without IDH-mutation. Using rat models of IDH1/2-mutant-overexpressing F98 glioma, Heo et al. (<span class="xref"><a href="#B22">22</a></span>) also describe the challenges with 1H-MRS of 2HG even at 9.4T. Given that spectral baseline is the primary factor hindering the differentiation between Glu and Gln (<span class="xref"><a href="#B37">37</a></span><span class="xref"><span class="gen">, </span><a href="#B38">38</a></span>), that the main signal of 2HG directly overlaps with these metabolites, and that measured spectral baseline provides better information than those modeled (<span class="xref"><a href="#B39">39</a></span><span class="xref"><span class="gen">, </span><a href="#B40">40</a></span>), they investigated the performance of a short TE method in combination with voxel-specifically measured spectral baseline, and report 100% sensitivity and 83% specificity.</p>
<p>Overall, the reported sensitivity and specificity of a short TE method ranges 77–100% and 72–100%, respectively, and there is a trend towards lower specificity than sensitivity. Despite the severe spectral overlaps, these results support the potential applicability of 1H-MRS in the non-invasive detection of 2HG. However, the reported limitation of the short TE method should be noted.</p>
</div>
<div>
<p class="tl-lowest-section">Long TE</p>
<p>Choi et al. (<span class="xref"><a href="#B16">16</a></span><span class="xref"><span class="gen">, </span><a href="#B17">17</a></span>) report 100% sensitivity and specificity in two different patient studies with a long TE method. In comparison to a short TE method, the long TE method improves the sensitivity from 77% to 100% (<span class="xref"><a href="#B17">17</a></span>). Using a long TE method, de la Fuente et al. (<span class="xref"><a href="#B19">19</a></span>) investigate the impact of voxel size on the detectability of 2HG. Three different voxel sizes of &lt; 3.4 mL, ≥ 3.4 and &lt; 8 mL, and ≥ 8 mL result in 8% (2/24), 47% (16/34), and 91% (20/22) sensitivity. Also, 6 of the 6 voxels (voxel size ≥ 8 mL) from IDH-WT gliomas do not show 2HG signal at the target spectral region. In this study, 2HG concentrations are correlated with tumor cellularity but not with the degree of tumor cell proliferation. Importantly, 2HG levels gradually reduce following treatment with radiation and chemotherapy. A long TE method is also tested at 7T by Emir et al. (<span class="xref"><a href="#B21">21</a></span>) where the specificity from 29 healthy or IDH-WT glioma tissue is 93% (sensitivity data not shown explicitly). Although a small number of voxels is used, the 2HG concentrations are higher in IDH2-MT gliomas (n = 3) than in IDH1-MT gliomas (n = 7) in that study.</p>
<p>Overall, the reported sensitivity and specificity with a long TE method are ~90–100% for both, and appear better than those with a short TE method, most likely due to the effective isolation of the target 2HG signal and negligible contribution from spectral baseline at a total TE of ~100 ms (<span class="xref"><a href="#B16">16</a></span><span class="xref"><span class="gen">, </span><a href="#B17">17</a></span>). However, as discussed by the authors (<span class="xref"><a href="#B16">16</a></span><span class="xref"><span class="gen">, </span><a href="#B17">17</a></span><span class="xref"><span class="gen">, </span><a href="#B21">21</a></span>), the resulting 2HG content may be prone to quantitative errors resulting from signal loss due to relaxation. The signal loss arising from a long TE may also hinder the quantification of other metabolites in the edited spectra (<span class="xref"><a href="#B21">21</a></span>).</p>
</div>
<div>
<p class="tl-lowest-section">Difference Editing and 2D</p>
<p>Using a difference editing method (<span class="xref"><a href="#B49">49</a></span>), Choi et al. (<span class="xref"><a href="#B16">16</a></span>) acquire spectra from 7 subjects with either IDH-MT or -WT gliomas. Although the mutational status of the patients is not given explicitly, the diagnostic outcome with difference editing is comparable to a long TE method with 100% sensitivity and specificity. Andronesi et al. (<span class="xref"><a href="#B15">15</a></span>) also test a difference editing method (<span class="xref"><a href="#B49">49</a></span>) together with a 2D method in 10 humans including 2 IDH-MT glioma patients. In their study, the mean 2HG levels (normalized to Glu + Gln) from IDH-WT voxels are non-zero with both methods; however, they are substantially lower than with a short TE method.</p>
<p>To date, the performance of a difference editing method in IDH-MT gliomas is reported from only 2 studies with small numbers of subjects (<span class="xref"><a href="#B15">15</a></span><span class="xref"><span class="gen">, </span><a href="#B16">16</a></span>)–only 1 study for a 2D method (<span class="xref"><a href="#B15">15</a></span>). However, given the effective isolation of a target signal provided by a difference editing method and the additional information for unambiguous peak assignment provided by a 2D method, these methods have potential applicability.</p>
</div>
<div>
<p class="tl-lowest-section">Alterations in the Concentrations of Other Metabolites in IDH-MT Gliomas</p>
<p>Pope et al. (<span class="xref"><a href="#B14">14</a></span>) report that voxels that result in the 4 false positive cases in their study have higher Glu and Gln levels than other IDH-WT voxels. This observation emphasizes the influence of the background signals on the quantification of 2HG in the spectral fitting. However, no difference in Glu and Gln concentrations are found between the study cohorts with and without IDH-mutation as measured by LC-MS. In contrast to these findings, Choi et al. (<span class="xref"><a href="#B17">17</a></span>) report reduced Glu and elevated Gln levels in IDH-MT gliomas relative to IDH-WT gliomas, but with no correlations with 2HG levels. Several other studies also report altered Glu and/or Gln levels in IDH-MT glioma patients (e.g., significantly lower Glu + Gln (<span class="xref"><a href="#B18">18</a></span>) and a trend of lower Glu (<span class="xref"><a href="#B21">21</a></span>)) and animal models (e.g., lowered Glu/Cho ratio (<span class="xref"><a href="#B20">20</a></span>)).</p>
<p>Significantly lowered GSH concentrations (<span class="xref"><a href="#B14">14</a></span><span class="xref"><span class="gen">, </span><a href="#B18">18</a></span>) as well as a trend of lower GSH (<span class="xref"><a href="#B21">21</a></span>) are also reported in IDH-MT glioma patients. This may be due to reduced nicotinamide adenine dinucleotide phosphate hydrate as a result of IDH-mutation, which is involved in the regeneration of the reduced form of GSH, and therefore may potentially be associated with the pathogenesis and progression of the IDH-MT gliomas (<span class="xref"><a href="#B14">14</a></span>). In an animal study, however, there is no difference in GSH concentrations normalized to Cho between the animal groups with and without IDH-mutation (<span class="xref"><a href="#B20">20</a></span>). Pope et al. (<span class="xref"><a href="#B14">14</a></span>) also report high Cho/Cr ratios in IDH-MT gliomas relative to those in IDH-WT gliomas, and suggest increased cell density from IDH-mutation-mediated cell proliferation as a probable cause. In addition, Emir et al. (<span class="xref"><a href="#B21">21</a></span>) report trends of lower citrate, mI, Cho and Cr, and higher Lac, NAA + NAAG and glucose + taurine in IDH-MT glioma patients than in IDH-WT glioma patients.</p>
<p>These <i>in-vivo</i> findings clearly need to be supported by further studies. Also, findings obtained at long TE may be prone to quantitative errors (<span class="xref"><a href="#B16">16</a></span><span class="xref"><span class="gen">, </span><a href="#B17">17</a></span><span class="xref"><span class="gen">, </span><a href="#B21">21</a></span>). Nonetheless, the altered Glu levels found in the majority of the <i>in-vivo</i> studies (<span class="xref"><a href="#B17">17</a></span><span class="xref"><span class="gen">, </span><a href="#B18">18</a></span><span class="xref"><span class="gen">, </span><a href="#B20">20</a></span><span class="xref"><span class="gen">, </span><a href="#B21">21</a></span>) are in line with the previous findings (<span class="xref"><a href="#B12">12</a></span><span class="xref"><span class="gen">, </span><a href="#B58">58</a></span>).</p>
</div>
<div>
<p class="tl-lowest-section">Data Inclusion/Exclusion Criteria and Presentation of 2HG Concentrations</p>
<p>Depending on their quality, spectra may need to be excluded prior to metabolite quantification. For instance, de la Fuente et al. (<span class="xref"><a href="#B19">19</a></span>) estimate the full-width-at-half-maximum (FWHM) of Cr signal, and those spectra with FWHM of Cr ≥ 0.08 ppm (~10 Hz at 3T) are excluded. However, even after such data screening, indeterminate diagnostic cases frequently occur after spectral fitting if the resulting CRLBs of 2HG are larger than a cutoff CRLB for successful fitting (e.g., CRLB ≤ 20%). To address this issue, various data inclusion/exclusion criteria are reported in terms of a detectable limit of 2HG concentrations in combination with a cutoff CRLB. For instance, Choi et al. (<span class="xref"><a href="#B16">16</a></span>) use 2HG concentrations ≥ 1.5 mM with CRLB &lt; 18% as the inclusion criteria for 2HG-positive cases. Natsumeda et al. (<span class="xref"><a href="#B18">18</a></span>) use different criteria for different metabolites in consideration of their different concentrations and thus different SNR in the spectra. The experimental settings in the previous studies are quite diverse (<span class="fig-table-link"><a href="#T1">Table 1</a></span>), and consequently the reported detection limits of 2HG concentrations are also quite different (<span class="xref"><a href="#B15">15</a></span><span class="xref"><span class="gen">, </span><a href="#B16">16</a></span><span class="xref"><span class="gen">, </span><a href="#B19">19</a></span>), indicating the need for experimental setting-specific data inclusion/exclusion criteria.<div class="image-at-section"></div></p>
<p>Water signal is most widely used as an internal reference for the normalization of the 1H-MRS-measured concentrations of 2HG and other metabolites (<span class="xref"><a href="#B14">14</a></span><span class="xref"><span class="gen">, </span><a href="#B16">16</a></span><span class="xref"><span class="gen">, </span><a href="#B17">17</a></span><span class="xref"><span class="gen">, </span><a href="#B18">18</a></span><span class="xref"><span class="gen">, </span><a href="#B19">19</a></span><span class="xref"><span class="gen">, </span><a href="#B21">21</a></span><span class="xref"><span class="gen">, </span><a href="#B22">22</a></span>). Water-normalized metabolite content can be further converted into absolute concentrations using a priori knowledge (<span class="xref"><a href="#B16">16</a></span><span class="xref"><span class="gen">, </span><a href="#B17">17</a></span><span class="xref"><span class="gen">, </span><a href="#B19">19</a></span>). Depending on the TE used for acquiring water-unsuppressed spectra, the water signal needs to be corrected for T2 relaxation (<span class="xref"><a href="#B21">21</a></span>). Alternatively, water-unsuppressed data need to be acquired using a STEAM sequence (<span class="xref"><a href="#B17">17</a></span>) which provides a shorter TE than a PRESS sequence. For spectra acquired at a long TE, T2 of metabolites can also be corrected based on the published data (<span class="xref"><a href="#B16">16</a></span><span class="xref"><span class="gen">, </span><a href="#B17">17</a></span><span class="xref"><span class="gen">, </span><a href="#B19">19</a></span>). In this procedure, however, care must be taken as different tumor types and grades can result in different T2 of water and other metabolites (<span class="xref"><a href="#B21">21</a></span><span class="xref"><span class="gen">, </span><a href="#B47">47</a></span>). By using water content as a reference, the reported ranges of 2HG concentrations in IDH-MT glioma voxels in patients are: 1.7–8.9 mM (<span class="xref"><a href="#B16">16</a></span>), 2–15 mM (<span class="xref"><a href="#B18">18</a></span>), and 2–10 umol/g (<span class="xref"><a href="#B21">21</a></span>). In addition to water, Glu + Gln (<span class="xref"><a href="#B15">15</a></span>), Cr (<span class="xref"><a href="#B14">14</a></span>), and Cho (<span class="xref"><a href="#B20">20</a></span>) are also used as an internal reference. In particular, Andronesi et al. (<span class="xref"><a href="#B15">15</a></span>) propose normalization of 2HG by Glu + Gln based on their potential inter-relationship (<span class="xref"><a href="#B12">12</a></span><span class="xref"><span class="gen">, </span><a href="#B58">58</a></span>), and report that a 2HG/(Glu + Gln) ratio of &gt; 1 could be specific for IDH1-mutations.</p>
</div>
</div>

<div xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl">
<table width="100%"><tr><td class="td-section">
<div class="goto">
<a class="ArticleGotoNagivator" href="#ArticleGotoNagivator" title="Go to other sections in this page" rolde="button" aria-expanded="false">Go to:</a><a class="__SECTION__" id="#__ID_SECTION_CONCLUSION" name="#__ID_SECTION_CONCLUSION"></a><div class="goto_section"></div>
</div>
<div class="tl-main-part">CONCLUSION</div>
</td></tr></table>

<p>In this review, we focused on technical aspects of previous in-vivo 1H-MRS studies of 2HG. Given that different experimental protocols were used with different data inclusion/exclusion criteria in the previous studies, and that there was a large inter-patient variability in reported 2HG content, the relative performance of the different 1H-MRS methods may be best compared in the same study cohort with established procedures for screening, post-processing, interpretation and presentation of the data. 1H-MRS methods have individual pros and cons; hence, further technical development may be necessary in order to accurately quantify the target metabolite and better depict biochemical effects of mutation-dependent IDH activities as a consumer or producer of α-KG. However, as far as 'detection' of 2HG is concerned, these previous pioneering studies are in support of the diagnostic and prognostic potential of 1H-MRS in IDH-MT glioma patients. IDH-mutations and/or 2HG accumulations are recently identified in other cancers and disorders (<span class="xref"><a href="#B59">59</a></span><span class="xref"><span class="gen">, </span><a href="#B60">60</a></span><span class="xref"><span class="gen">, </span><a href="#B61">61</a></span><span class="xref"><span class="gen">, </span><a href="#B62">62</a></span><span class="xref"><span class="gen">, </span><a href="#B63">63</a></span><span class="xref"><span class="gen">, </span><a href="#B64">64</a></span><span class="xref"><span class="gen">, </span><a href="#B65">65</a></span><span class="xref"><span class="gen">, </span><a href="#B66">66</a></span>). Therefore, the efficacy of 2HG as a 1H-MRS biomarker of IDH-MT gliomas should also be investigated thoroughly (<span class="xref"><a href="#B18">18</a></span>).</p>
</div>

<div xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" id="supplementary-material"><p></p></div>
</div>

<div id="article-level-0-figs-and-tables" class="bm bm-figure-tables">

</div>

<div id="article-level-0-back" class="bm">
<table width="100%"><tr><td class="td-section">
<div xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" class="goto">
<a class="ArticleGotoNagivator" href="#ArticleGotoNagivator" title="Go to other sections in this page" rolde="button" aria-expanded="false">Go to:</a><a class="__SECTION__" id="#__ID_SECTION_Notes" name="#__ID_SECTION_Notes"></a><div class="goto_section"></div>
</div>
<div class="tl-main-part">Notes</div>
</td></tr></table>
<div xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" id=""><p>This study was supported by a grant from the Ministry for Health, Welfare &amp; Family Affairs (HI13C0015) in Korea, and by a grant from Seoul National University College of Medicine (800-20130068).</p></div>

<div class="capture-id">
<table xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" width="100%"><tr><td class="td-section">
<div class="goto">
<a class="ArticleGotoNagivator" href="#ArticleGotoNagivator" title="Go to other sections in this page" rolde="button" aria-expanded="false">Go to:</a><a class="__SECTION__" id="#__ID_SECTION_Acknowledgments" name="#__ID_SECTION_Acknowledgments"></a><div class="goto_section"></div>
</div>
<div class="tl-main-part">Acknowledgments</div>
</td></tr></table>

<p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl">The authors gratefully acknowledge Drs. Seung Hong Choi (Radiology), Chul-Kee Park (Neurosurgery), and Sunghyouk Park (Natural Product Research Institute) at Seoul National University/Hospital for sharing their expertise in the preparation of the manuscript.</p>
</div>
<table width="100%"><tr><td class="td-section">
<div xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" class="goto">
<a class="ArticleGotoNagivator" href="#ArticleGotoNagivator" title="Go to other sections in this page" rolde="button" aria-expanded="false">Go to:</a><a class="__SECTION__" id="#__ID_SECTION_References" name="#__ID_SECTION_References"></a><div class="goto_section"></div>
</div>
<div class="tl-main-part">References</div>
</td></tr></table>
<table width="100%" class="bm">
<tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl">
<td></td>
<td></td>
</tr>
<tr>
<td id="B1" valign="top" align="left"><b xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl"><i>1. </i></b></td>
<td valign="top">Law M, Yang S, Wang H, Babb JS, Johnson G, Cha S, et al. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. AJNR Am J Neuroradiol 2003;24:1989–1998.<div>
<!--[KOREAMED SYNAPSE REFID:B1] *** BEGIN ***--><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://www.ncbi.nlm.nih.gov/sites/entrez?db=PubMed&amp;cmd=Retrieve&amp;list_uids=14625221" target="_new"><IMG SRC="image/ReficonPubmed.gif" BORDER="0"></a><!--[KOREAMED SYNAPSE REFID:B1] *** END ***-->
</div>
</td>
</tr>
<tr height="15"><td></td></tr>
<tr>
<td id="B2" valign="top" align="left"><b xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl"><i>2. </i></b></td>
<td valign="top">Möller-Hartmann W, Herminghaus S, Krings T, Marquardt G, Lanfermann H, Pilatus U, et al. Clinical application of proton magnetic resonance spectroscopy in the diagnosis of intracranial mass lesions. Neuroradiology 2002;44:371–381.<div>
<!--[KOREAMED SYNAPSE REFID:B2] *** BEGIN ***--><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://doi.org/10.1007%2Fs00234-001-0760-0" target="_new"><IMG SRC="image/ReficonCrossRef.gif" BORDER="0"></a><!--[KOREAMED SYNAPSE REFID:B2] *** END ***-->
</div>
</td>
</tr>
<tr height="15"><td></td></tr>
<tr>
<td id="B3" valign="top" align="left"><b xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl"><i>3. </i></b></td>
<td valign="top">Herholz K, Heindel W, Luyten PR, denHollander JA, Pietrzyk U, Voges J, et al. In vivo imaging of glucose consumption and lactate concentration in human gliomas. Ann Neurol 1992;31:319–327.<div>
<!--[KOREAMED SYNAPSE REFID:B3] *** BEGIN ***--><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://www.ncbi.nlm.nih.gov/sites/entrez?db=PubMed&amp;cmd=Retrieve&amp;list_uids=1637139" target="_new"><IMG SRC="image/ReficonPubmed.gif" BORDER="0"></a><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://doi.org/10.1002%2Fana.410310315" target="_new"><IMG SRC="image/ReficonCrossRef.gif" BORDER="0"></a><!--[KOREAMED SYNAPSE REFID:B3] *** END ***-->
</div>
</td>
</tr>
<tr height="15"><td></td></tr>
<tr>
<td id="B4" valign="top" align="left"><b xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl"><i>4. </i></b></td>
<td valign="top">Rock JP, Scarpace L, Hearshen D, Gutierrez J, Fisher JL, Rosenblum M, et al. Associations among magnetic resonance spectroscopy, apparent diffusion coefficients, and image-guided histopathology with special attention to radiation necrosis. Neurosurgery 2004;54:1111–1117. <div class="citation-comment">discussion 1117-1119.</div>
<div>
<!--[KOREAMED SYNAPSE REFID:B4] *** BEGIN ***--><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://www.ncbi.nlm.nih.gov/sites/entrez?db=PubMed&amp;cmd=Retrieve&amp;list_uids=15113465" target="_new"><IMG SRC="image/ReficonPubmed.gif" BORDER="0"></a><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://doi.org/10.1227%2F01.NEU.0000119328.56431.A7" target="_new"><IMG SRC="image/ReficonCrossRef.gif" BORDER="0"></a><!--[KOREAMED SYNAPSE REFID:B4] *** END ***-->
</div>
</td>
</tr>
<tr height="15"><td></td></tr>
<tr>
<td id="B5" valign="top" align="left"><b xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl"><i>5. </i></b></td>
<td valign="top">Verma N, Cowperthwaite MC, Burnett MG, Markey MK. Differentiating tumor recurrence from treatment necrosis: a review of neuro-oncologic imaging strategies. Neuro Oncol 2013;15:515–534.<div>
<!--[KOREAMED SYNAPSE REFID:B5] *** BEGIN ***--><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://www.ncbi.nlm.nih.gov/sites/entrez?db=PubMed&amp;cmd=Retrieve&amp;list_uids=23325863" target="_new"><IMG SRC="image/ReficonPubmed.gif" BORDER="0"></a><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://doi.org/10.1093%2Fneuonc%2Fnos307" target="_new"><IMG SRC="image/ReficonCrossRef.gif" BORDER="0"></a><!--[KOREAMED SYNAPSE REFID:B5] *** END ***-->
</div>
</td>
</tr>
<tr height="15"><td></td></tr>
<tr>
<td id="B6" valign="top" align="left"><b xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl"><i>6. </i></b></td>
<td valign="top">Blüml S, Panigrahy A, Laskov M, Dhall G, Krieger MD, Nelson MD, et al. Elevated citrate in pediatric astrocytomas with malignant progression. Neuro Oncol 2011;13:1107–1117.<div>
<!--[KOREAMED SYNAPSE REFID:B6] *** BEGIN ***--><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://doi.org/10.1093%2Fneuonc%2Fnor087" target="_new"><IMG SRC="image/ReficonCrossRef.gif" BORDER="0"></a><!--[KOREAMED SYNAPSE REFID:B6] *** END ***-->
</div>
</td>
</tr>
<tr height="15"><td></td></tr>
<tr>
<td id="B7" valign="top" align="left"><b xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl"><i>7. </i></b></td>
<td valign="top">Howe FA, Barton SJ, Cudlip SA, Stubbs M, Saunders DE, Murphy M, et al. Metabolic profiles of human brain tumors using quantitative in vivo 1H magnetic resonance spectroscopy. Magn Reson Med 2003;49:223–232.<div>
<!--[KOREAMED SYNAPSE REFID:B7] *** BEGIN ***--><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://www.ncbi.nlm.nih.gov/sites/entrez?db=PubMed&amp;cmd=Retrieve&amp;list_uids=12541241" target="_new"><IMG SRC="image/ReficonPubmed.gif" BORDER="0"></a><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://doi.org/10.1002%2Fmrm.10367" target="_new"><IMG SRC="image/ReficonCrossRef.gif" BORDER="0"></a><!--[KOREAMED SYNAPSE REFID:B7] *** END ***-->
</div>
</td>
</tr>
<tr height="15"><td></td></tr>
<tr>
<td id="B8" valign="top" align="left"><b xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl"><i>8. </i></b></td>
<td valign="top">Majós C, Alonso J, Aguilera C, Serrallonga M, Pérez-Martín J, Acebes JJ, et al. Proton magnetic resonance spectroscopy ((1) H MRS) of human brain tumours: assessment of differences between tumour types and its applicability in brain tumour categorization. Eur Radiol 2003;13:582–591.<div>
<!--[KOREAMED SYNAPSE REFID:B8] *** BEGIN ***--><!--[KOREAMED SYNAPSE REFID:B8] *** END ***-->
</div>
</td>
</tr>
<tr height="15"><td></td></tr>
<tr>
<td id="B9" valign="top" align="left"><b xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl"><i>9. </i></b></td>
<td valign="top">Zonari P, Baraldi P, Crisi G. Multimodal MRI in the characterization of glial neoplasms: the combined role of single-voxel MR spectroscopy, diffusion imaging and echo-planar perfusion imaging. Neuroradiology 2007;49:795–803.<div>
<!--[KOREAMED SYNAPSE REFID:B9] *** BEGIN ***--><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://www.ncbi.nlm.nih.gov/sites/entrez?db=PubMed&amp;cmd=Retrieve&amp;list_uids=17619871" target="_new"><IMG SRC="image/ReficonPubmed.gif" BORDER="0"></a><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://doi.org/10.1007%2Fs00234-007-0253-x" target="_new"><IMG SRC="image/ReficonCrossRef.gif" BORDER="0"></a><!--[KOREAMED SYNAPSE REFID:B9] *** END ***-->
</div>
</td>
</tr>
<tr height="15"><td></td></tr>
<tr>
<td id="B10" valign="top" align="left"><b xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl"><i>10. </i></b></td>
<td valign="top">Parsons DW, Jones S, Zhang X, Lin JC, Leary RJ, Angenendt P, et al. An integrated genomic analysis of human glioblastoma multiforme. Science 2008;321:1807–1812.<div>
<!--[KOREAMED SYNAPSE REFID:B10] *** BEGIN ***--><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://www.ncbi.nlm.nih.gov/sites/entrez?db=PubMed&amp;cmd=Retrieve&amp;list_uids=18772396" target="_new"><IMG SRC="image/ReficonPubmed.gif" BORDER="0"></a><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://doi.org/10.1126%2Fscience.1164382" target="_new"><IMG SRC="image/ReficonCrossRef.gif" BORDER="0"></a><!--[KOREAMED SYNAPSE REFID:B10] *** END ***-->
</div>
</td>
</tr>
<tr height="15"><td></td></tr>
<tr>
<td id="B11" valign="top" align="left"><b xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl"><i>11. </i></b></td>
<td valign="top">Yan H, Parsons DW, Jin G, McLendon R, Rasheed BA, Yuan W, et al. IDH1 and IDH2 mutations in gliomas. N Engl J Med 2009;360:765–773.<div>
<!--[KOREAMED SYNAPSE REFID:B11] *** BEGIN ***--><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://www.ncbi.nlm.nih.gov/sites/entrez?db=PubMed&amp;cmd=Retrieve&amp;list_uids=19228619" target="_new"><IMG SRC="image/ReficonPubmed.gif" BORDER="0"></a><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://doi.org/10.1056%2FNEJMoa0808710" target="_new"><IMG SRC="image/ReficonCrossRef.gif" BORDER="0"></a><!--[KOREAMED SYNAPSE REFID:B11] *** END ***-->
</div>
</td>
</tr>
<tr height="15"><td></td></tr>
<tr>
<td id="B12" valign="top" align="left"><b xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl"><i>12. </i></b></td>
<td valign="top">Dang L, White DW, Gross S, Bennett BD, Bittinger MA, Driggers EM, et al. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 2009;462:739–744.<div>
<!--[KOREAMED SYNAPSE REFID:B12] *** BEGIN ***--><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://www.ncbi.nlm.nih.gov/sites/entrez?db=PubMed&amp;cmd=Retrieve&amp;list_uids=19935646" target="_new"><IMG SRC="image/ReficonPubmed.gif" BORDER="0"></a><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://doi.org/10.1038%2Fnature08617" target="_new"><IMG SRC="image/ReficonCrossRef.gif" BORDER="0"></a><!--[KOREAMED SYNAPSE REFID:B12] *** END ***-->
</div>
</td>
</tr>
<tr height="15"><td></td></tr>
<tr>
<td id="B13" valign="top" align="left"><b xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl"><i>13. </i></b></td>
<td valign="top">Andronesi OC, Rapalino O, Gerstner E, Chi A, Batchelor TT, Cahill DP, et al. Detection of oncogenic IDH1 mutations using magnetic resonance spectroscopy of 2-hydroxyglutarate. J Clin Invest 2013;123:3659–3663.<div>
<!--[KOREAMED SYNAPSE REFID:B13] *** BEGIN ***--><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://www.ncbi.nlm.nih.gov/sites/entrez?db=PubMed&amp;cmd=Retrieve&amp;list_uids=23999439" target="_new"><IMG SRC="image/ReficonPubmed.gif" BORDER="0"></a><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://doi.org/10.1172%2FJCI67229" target="_new"><IMG SRC="image/ReficonCrossRef.gif" BORDER="0"></a><!--[KOREAMED SYNAPSE REFID:B13] *** END ***-->
</div>
</td>
</tr>
<tr height="15"><td></td></tr>
<tr>
<td id="B14" valign="top" align="left"><b xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl"><i>14. </i></b></td>
<td valign="top">Pope WB, Prins RM, Albert Thomas M, Nagarajan R, Yen KE, Bittinger MA, et al. Non-invasive detection of 2-hydroxyglutarate and other metabolites in IDH1 mutant glioma patients using magnetic resonance spectroscopy. J Neurooncol 2012;107:197–205.<div>
<!--[KOREAMED SYNAPSE REFID:B14] *** BEGIN ***--><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://www.ncbi.nlm.nih.gov/sites/entrez?db=PubMed&amp;cmd=Retrieve&amp;list_uids=22015945" target="_new"><IMG SRC="image/ReficonPubmed.gif" BORDER="0"></a><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://doi.org/10.1007%2Fs11060-011-0737-8" target="_new"><IMG SRC="image/ReficonCrossRef.gif" BORDER="0"></a><!--[KOREAMED SYNAPSE REFID:B14] *** END ***-->
</div>
</td>
</tr>
<tr height="15"><td></td></tr>
<tr>
<td id="B15" valign="top" align="left"><b xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl"><i>15. </i></b></td>
<td valign="top">Andronesi OC, Kim GS, Gerstner E, Batchelor T, Tzika AA, Fantin VR, et al. Detection of 2-hydroxyglutarate in IDH-mutated glioma patients by in vivo spectral-editing and 2D correlation magnetic resonance spectroscopy. Sci Transl Med 2012;4:116ra4.<div>
<!--[KOREAMED SYNAPSE REFID:B15] *** BEGIN ***--><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://www.ncbi.nlm.nih.gov/sites/entrez?db=PubMed&amp;cmd=Retrieve&amp;list_uids=22238332" target="_new"><IMG SRC="image/ReficonPubmed.gif" BORDER="0"></a><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://doi.org/10.1126%2Fscitranslmed.3002693" target="_new"><IMG SRC="image/ReficonCrossRef.gif" BORDER="0"></a><!--[KOREAMED SYNAPSE REFID:B15] *** END ***-->
</div>
</td>
</tr>
<tr height="15"><td></td></tr>
<tr>
<td id="B16" valign="top" align="left"><b xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl"><i>16. </i></b></td>
<td valign="top">Choi C, Ganji SK, DeBerardinis RJ, Hatanpaa KJ, Rakheja D, Kovacs Z, et al. 2-hydroxyglutarate detection by magnetic resonance spectroscopy in IDH-mutated patients with gliomas. Nat Med 2012;18:624–629.<div>
<!--[KOREAMED SYNAPSE REFID:B16] *** BEGIN ***--><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://www.ncbi.nlm.nih.gov/sites/entrez?db=PubMed&amp;cmd=Retrieve&amp;list_uids=22281806" target="_new"><IMG SRC="image/ReficonPubmed.gif" BORDER="0"></a><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://doi.org/10.1038%2Fnm.2682" target="_new"><IMG SRC="image/ReficonCrossRef.gif" BORDER="0"></a><!--[KOREAMED SYNAPSE REFID:B16] *** END ***-->
</div>
</td>
</tr>
<tr height="15"><td></td></tr>
<tr>
<td id="B17" valign="top" align="left"><b xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl"><i>17. </i></b></td>
<td valign="top">Choi C, Ganji S, Hulsey K, Madan A, Kovacs Z, Dimitrov I, et al. A comparative study of short- and long-TE <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl">1</sup>H MRS at 3 T for in vivo detection of 2-hydroxyglutarate in brain tumors. NMR Biomed 2013;26:1242–1250.<div>
<!--[KOREAMED SYNAPSE REFID:B17] *** BEGIN ***--><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://www.ncbi.nlm.nih.gov/sites/entrez?db=PubMed&amp;cmd=Retrieve&amp;list_uids=23592268" target="_new"><IMG SRC="image/ReficonPubmed.gif" BORDER="0"></a><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://doi.org/10.1002%2Fnbm.2943" target="_new"><IMG SRC="image/ReficonCrossRef.gif" BORDER="0"></a><!--[KOREAMED SYNAPSE REFID:B17] *** END ***-->
</div>
</td>
</tr>
<tr height="15"><td></td></tr>
<tr>
<td id="B18" valign="top" align="left"><b xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl"><i>18. </i></b></td>
<td valign="top">Natsumeda M, Igarashi H, Nomura T, Ogura R, Tsukamoto Y, Kobayashi T, et al. Accumulation of 2-hydroxyglutarate in gliomas correlates with survival: a study by 3.0-tesla magnetic resonance spectroscopy. Acta Neuropathol Commun 2014;2:158.<div>
<!--[KOREAMED SYNAPSE REFID:B18] *** BEGIN ***--><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://www.ncbi.nlm.nih.gov/sites/entrez?db=PubMed&amp;cmd=Retrieve&amp;list_uids=25376594" target="_new"><IMG SRC="image/ReficonPubmed.gif" BORDER="0"></a><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://doi.org/10.1186%2Fs40478-014-0158-y" target="_new"><IMG SRC="image/ReficonCrossRef.gif" BORDER="0"></a><!--[KOREAMED SYNAPSE REFID:B18] *** END ***-->
</div>
</td>
</tr>
<tr height="15"><td></td></tr>
<tr>
<td id="B19" valign="top" align="left"><b xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl"><i>19. </i></b></td>
<td valign="top">de la Fuente MI, Young RJ, Rubel J, Rosenblum M, Tisnado J, Briggs S, et al. Integration of 2-hydroxyglutarate-proton magnetic resonance spectroscopy into clinical practice for disease monitoring in isocitrate dehydrogenase-mutant glioma. Neuro Oncol 2016;18:283–290.<div>
<!--[KOREAMED SYNAPSE REFID:B19] *** BEGIN ***--><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://www.ncbi.nlm.nih.gov/sites/entrez?db=PubMed&amp;cmd=Retrieve&amp;list_uids=26691210" target="_new"><IMG SRC="image/ReficonPubmed.gif" BORDER="0"></a><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://doi.org/10.1093%2Fneuonc%2Fnov307" target="_new"><IMG SRC="image/ReficonCrossRef.gif" BORDER="0"></a><!--[KOREAMED SYNAPSE REFID:B19] *** END ***-->
</div>
</td>
</tr>
<tr height="15"><td></td></tr>
<tr>
<td id="B20" valign="top" align="left"><b xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl"><i>20. </i></b></td>
<td valign="top">Lazovic J, Soto H, Piccioni D, Lou JR, Li S, Mirsadraei L, et al. Detection of 2-hydroxyglutaric acid in vivo by proton magnetic resonance spectroscopy in U87 glioma cells overexpressing isocitrate dehydrogenase-1 mutation. Neuro Oncol 2012;14:1465–1472.<div>
<!--[KOREAMED SYNAPSE REFID:B20] *** BEGIN ***--><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://www.ncbi.nlm.nih.gov/sites/entrez?db=PubMed&amp;cmd=Retrieve&amp;list_uids=23090985" target="_new"><IMG SRC="image/ReficonPubmed.gif" BORDER="0"></a><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://doi.org/10.1093%2Fneuonc%2Fnos258" target="_new"><IMG SRC="image/ReficonCrossRef.gif" BORDER="0"></a><!--[KOREAMED SYNAPSE REFID:B20] *** END ***-->
</div>
</td>
</tr>
<tr height="15"><td></td></tr>
<tr>
<td id="B21" valign="top" align="left"><b xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl"><i>21. </i></b></td>
<td valign="top">Emir UE, Larkin SJ, de Pennington N, Voets N, Plaha P, Stacey R, et al. Noninvasive quantification of 2-hydroxyglutarate in human gliomas with IDH1 and IDH2 mutations. Cancer Res 2016;76:43–49.<div>
<!--[KOREAMED SYNAPSE REFID:B21] *** BEGIN ***--><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://www.ncbi.nlm.nih.gov/sites/entrez?db=PubMed&amp;cmd=Retrieve&amp;list_uids=26669865" target="_new"><IMG SRC="image/ReficonPubmed.gif" BORDER="0"></a><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://doi.org/10.1158%2F0008-5472.CAN-15-0934" target="_new"><IMG SRC="image/ReficonCrossRef.gif" BORDER="0"></a><!--[KOREAMED SYNAPSE REFID:B21] *** END ***-->
</div>
</td>
</tr>
<tr height="15"><td></td></tr>
<tr>
<td id="B22" valign="top" align="left"><b xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl"><i>22. </i></b></td>
<td valign="top">Heo H, Kim S, Lee HH, Cho HR, Xu WJ, Lee SH, et al. On the utility of short echo time (TE) single voxel 1H-MRS in non-invasive detection of 2-hydroxyglutarate (2HG); challenges and potential improvement illustrated with animal models using MRUI and LCModel. PLoS One 2016;11:e0147794.<div>
<!--[KOREAMED SYNAPSE REFID:B22] *** BEGIN ***--><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://www.ncbi.nlm.nih.gov/sites/entrez?db=PubMed&amp;cmd=Retrieve&amp;list_uids=26820720" target="_new"><IMG SRC="image/ReficonPubmed.gif" BORDER="0"></a><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://doi.org/10.1371%2Fjournal.pone.0147794" target="_new"><IMG SRC="image/ReficonCrossRef.gif" BORDER="0"></a><!--[KOREAMED SYNAPSE REFID:B22] *** END ***-->
</div>
</td>
</tr>
<tr height="15"><td></td></tr>
<tr>
<td id="B23" valign="top" align="left"><b xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl"><i>23. </i></b></td>
<td valign="top">Yen KE, Bittinger MA, Su SM, Fantin VR. Cancer-associated IDH mutations: biomarker and therapeutic opportunities. Oncogene 2010;29:6409–6417.<div>
<!--[KOREAMED SYNAPSE REFID:B23] *** BEGIN ***--><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://www.ncbi.nlm.nih.gov/sites/entrez?db=PubMed&amp;cmd=Retrieve&amp;list_uids=20972461" target="_new"><IMG SRC="image/ReficonPubmed.gif" BORDER="0"></a><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://doi.org/10.1038%2Fonc.2010.444" target="_new"><IMG SRC="image/ReficonCrossRef.gif" BORDER="0"></a><!--[KOREAMED SYNAPSE REFID:B23] *** END ***-->
</div>
</td>
</tr>
<tr height="15"><td></td></tr>
<tr>
<td id="B24" valign="top" align="left"><b xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl"><i>24. </i></b></td>
<td valign="top">Esmaeili M, Vettukattil R, Bathen TF. 2-hydroxyglutarate as a magnetic resonance biomarker for glioma subtyping. Transl Oncol 2013;6:92–98.<div>
<!--[KOREAMED SYNAPSE REFID:B24] *** BEGIN ***--><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://www.ncbi.nlm.nih.gov/sites/entrez?db=PubMed&amp;cmd=Retrieve&amp;list_uids=23544162" target="_new"><IMG SRC="image/ReficonPubmed.gif" BORDER="0"></a><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://doi.org/10.1593%2Ftlo.12424" target="_new"><IMG SRC="image/ReficonCrossRef.gif" BORDER="0"></a><!--[KOREAMED SYNAPSE REFID:B24] *** END ***-->
</div>
</td>
</tr>
<tr height="15"><td></td></tr>
<tr>
<td id="B25" valign="top" align="left"><b xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl"><i>25. </i></b></td>
<td valign="top">Chaumeil MM, Larson PE, Woods SM, Cai L, Eriksson P, Robinson AE, et al. Hyperpolarized [1-13C] glutamate: a metabolic imaging biomarker of IDH1 mutational status in glioma. Cancer Res 2014;74:4247–4257.<div>
<!--[KOREAMED SYNAPSE REFID:B25] *** BEGIN ***--><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://www.ncbi.nlm.nih.gov/sites/entrez?db=PubMed&amp;cmd=Retrieve&amp;list_uids=24876103" target="_new"><IMG SRC="image/ReficonPubmed.gif" BORDER="0"></a><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://doi.org/10.1158%2F0008-5472.CAN-14-0680" target="_new"><IMG SRC="image/ReficonCrossRef.gif" BORDER="0"></a><!--[KOREAMED SYNAPSE REFID:B25] *** END ***-->
</div>
</td>
</tr>
<tr height="15"><td></td></tr>
<tr>
<td id="B26" valign="top" align="left"><b xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl"><i>26. </i></b></td>
<td valign="top">Tönjes M, Barbus S, Park YJ, Wang W, Schlotter M, Lindroth AM, et al. BCAT1 promotes cell proliferation through amino acid catabolism in gliomas carrying wild-type IDH1. Nat Med 2013;19:901–908.<div>
<!--[KOREAMED SYNAPSE REFID:B26] *** BEGIN ***--><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://doi.org/10.1038%2Fnm.3217" target="_new"><IMG SRC="image/ReficonCrossRef.gif" BORDER="0"></a><!--[KOREAMED SYNAPSE REFID:B26] *** END ***-->
</div>
</td>
</tr>
<tr height="15"><td></td></tr>
<tr>
<td id="B27" valign="top" align="left"><b xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl"><i>27. </i></b></td>
<td valign="top">Shi J, Sun B, Shi W, Zuo H, Cui D, Ni L, et al. Decreasing GSH and increasing ROS in chemosensitivity gliomas with IDH1 mutation. Tumour Biol 2015;36:655–662.<div>
<!--[KOREAMED SYNAPSE REFID:B27] *** BEGIN ***--><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://www.ncbi.nlm.nih.gov/sites/entrez?db=PubMed&amp;cmd=Retrieve&amp;list_uids=25283382" target="_new"><IMG SRC="image/ReficonPubmed.gif" BORDER="0"></a><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://doi.org/10.1007%2Fs13277-014-2644-z" target="_new"><IMG SRC="image/ReficonCrossRef.gif" BORDER="0"></a><!--[KOREAMED SYNAPSE REFID:B27] *** END ***-->
</div>
</td>
</tr>
<tr height="15"><td></td></tr>
<tr>
<td id="B28" valign="top" align="left"><b xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl"><i>28. </i></b></td>
<td valign="top">Marin-Valencia I, Yang C, Mashimo T, Cho S, Baek H, Yang XL, et al. Analysis of tumor metabolism reveals mitochondrial glucose oxidation in genetically diverse human glioblastomas in the mouse brain in vivo. Cell Metab 2012;15:827–837.<div>
<!--[KOREAMED SYNAPSE REFID:B28] *** BEGIN ***--><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://www.ncbi.nlm.nih.gov/sites/entrez?db=PubMed&amp;cmd=Retrieve&amp;list_uids=22682223" target="_new"><IMG SRC="image/ReficonPubmed.gif" BORDER="0"></a><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://doi.org/10.1016%2Fj.cmet.2012.05.001" target="_new"><IMG SRC="image/ReficonCrossRef.gif" BORDER="0"></a><!--[KOREAMED SYNAPSE REFID:B28] *** END ***-->
</div>
</td>
</tr>
<tr height="15"><td></td></tr>
<tr>
<td id="B29" valign="top" align="left"><b xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl"><i>29. </i></b></td>
<td valign="top">de Graaf RA. In: In vivo NMR spectroscopy: principles and techniques. 2nd ed. Chichester: John Wiley &amp; Sons; 2007. pp. 26-32.<div>
<!--[KOREAMED SYNAPSE REFID:B29] *** BEGIN ***--><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://doi.org/10.1002%2F9780470512968" target="_new"><IMG SRC="image/ReficonCrossRef.gif" BORDER="0"></a><!--[KOREAMED SYNAPSE REFID:B29] *** END ***-->
</div>
</td>
</tr>
<tr height="15"><td></td></tr>
<tr>
<td id="B30" valign="top" align="left"><b xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl"><i>30. </i></b></td>
<td valign="top">Allen PS, Thompson RB, Wilman AH. Metabolite-specific NMR spectroscopy in vivo. NMR Biomed 1997;10:435–444.<div>
<!--[KOREAMED SYNAPSE REFID:B30] *** BEGIN ***--><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://www.ncbi.nlm.nih.gov/sites/entrez?db=PubMed&amp;cmd=Retrieve&amp;list_uids=9542740" target="_new"><IMG SRC="image/ReficonPubmed.gif" BORDER="0"></a><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://doi.org/10.1002%2F%28SICI%291099-1492%28199712%2910%3A8%3C435%3A%3AAID-NBM480%3E3.0.CO%3B2-D" target="_new"><IMG SRC="image/ReficonCrossRef.gif" BORDER="0"></a><!--[KOREAMED SYNAPSE REFID:B30] *** END ***-->
</div>
</td>
</tr>
<tr height="15"><td></td></tr>
<tr>
<td id="B31" valign="top" align="left"><b xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl"><i>31. </i></b></td>
<td valign="top">Govindaraju V, Young K, Maudsley AA. Proton NMR chemical shifts and coupling constants for brain metabolites. NMR Biomed 2000;13:129–153.<div>
<!--[KOREAMED SYNAPSE REFID:B31] *** BEGIN ***--><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://www.ncbi.nlm.nih.gov/sites/entrez?db=PubMed&amp;cmd=Retrieve&amp;list_uids=10861994" target="_new"><IMG SRC="image/ReficonPubmed.gif" BORDER="0"></a><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://doi.org/10.1002%2F1099-1492%28200005%2913%3A3%3C129%3A%3AAID-NBM619%3E3.0.CO%3B2-V" target="_new"><IMG SRC="image/ReficonCrossRef.gif" BORDER="0"></a><!--[KOREAMED SYNAPSE REFID:B31] *** END ***-->
</div>
</td>
</tr>
<tr height="15"><td></td></tr>
<tr>
<td id="B32" valign="top" align="left"><b xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl"><i>32. </i></b></td>
<td valign="top">Bottomley PA. Selective volume method for performing localized NMR spectroscopy. United States patent US. 4480228. 1984 Oct 30. <div>
<!--[KOREAMED SYNAPSE REFID:B32] *** BEGIN ***--><!--[KOREAMED SYNAPSE REFID:B32] *** END ***-->
</div>
</td>
</tr>
<tr height="15"><td></td></tr>
<tr>
<td id="B33" valign="top" align="left"><b xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl"><i>33. </i></b></td>
<td valign="top">Frahm J, Bruhn H, Gyngell ML, Merboldt KD, Hänicke W, Sauter R. Localized high-resolution proton NMR spectroscopy using stimulated echoes: initial applications to human brain in vivo. Magn Reson Med 1989;9:79–93.<div>
<!--[KOREAMED SYNAPSE REFID:B33] *** BEGIN ***--><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://www.ncbi.nlm.nih.gov/sites/entrez?db=PubMed&amp;cmd=Retrieve&amp;list_uids=2540396" target="_new"><IMG SRC="image/ReficonPubmed.gif" BORDER="0"></a><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://doi.org/10.1002%2Fmrm.1910090110" target="_new"><IMG SRC="image/ReficonCrossRef.gif" BORDER="0"></a><!--[KOREAMED SYNAPSE REFID:B33] *** END ***-->
</div>
</td>
</tr>
<tr height="15"><td></td></tr>
<tr>
<td id="B34" valign="top" align="left"><b xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl"><i>34. </i></b></td>
<td valign="top">Behar KL, Rothman DL, Spencer DD, Petroff OA. Analysis of macromolecule resonances in 1H NMR spectra of human brain. Magn Reson Med 1994;32:294–302.<div>
<!--[KOREAMED SYNAPSE REFID:B34] *** BEGIN ***--><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://www.ncbi.nlm.nih.gov/sites/entrez?db=PubMed&amp;cmd=Retrieve&amp;list_uids=7984061" target="_new"><IMG SRC="image/ReficonPubmed.gif" BORDER="0"></a><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://doi.org/10.1002%2Fmrm.1910320304" target="_new"><IMG SRC="image/ReficonCrossRef.gif" BORDER="0"></a><!--[KOREAMED SYNAPSE REFID:B34] *** END ***-->
</div>
</td>
</tr>
<tr height="15"><td></td></tr>
<tr>
<td id="B35" valign="top" align="left"><b xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl"><i>35. </i></b></td>
<td valign="top">Seeger U, Klose U, Mader I, Grodd W, Nägele T. Parameterized evaluation of macromolecules and lipids in proton MR spectroscopy of brain diseases. Magn Reson Med 2003;49:19–28.<div>
<!--[KOREAMED SYNAPSE REFID:B35] *** BEGIN ***--><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://www.ncbi.nlm.nih.gov/sites/entrez?db=PubMed&amp;cmd=Retrieve&amp;list_uids=12509816" target="_new"><IMG SRC="image/ReficonPubmed.gif" BORDER="0"></a><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://doi.org/10.1002%2Fmrm.10332" target="_new"><IMG SRC="image/ReficonCrossRef.gif" BORDER="0"></a><!--[KOREAMED SYNAPSE REFID:B35] *** END ***-->
</div>
</td>
</tr>
<tr height="15"><td></td></tr>
<tr>
<td id="B36" valign="top" align="left"><b xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl"><i>36. </i></b></td>
<td valign="top">Auer DP, Gössl C, Schirmer T, Czisch M. Improved analysis of 1H-MR spectra in the presence of mobile lipids. Magn Reson Med 2001;46:615–618.<div>
<!--[KOREAMED SYNAPSE REFID:B36] *** BEGIN ***--><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://www.ncbi.nlm.nih.gov/sites/entrez?db=PubMed&amp;cmd=Retrieve&amp;list_uids=11550257" target="_new"><IMG SRC="image/ReficonPubmed.gif" BORDER="0"></a><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://doi.org/10.1002%2Fmrm.1235" target="_new"><IMG SRC="image/ReficonCrossRef.gif" BORDER="0"></a><!--[KOREAMED SYNAPSE REFID:B36] *** END ***-->
</div>
</td>
</tr>
<tr height="15"><td></td></tr>
<tr>
<td id="B37" valign="top" align="left"><b xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl"><i>37. </i></b></td>
<td valign="top">Hofmann L, Slotboom J, Jung B, Maloca P, Boesch C, Kreis R. Quantitative 1H-magnetic resonance spectroscopy of human brain: influence of composition and parameterization of the basis set in linear combination model-fitting. Magn Reson Med 2002;48:440–453.<div>
<!--[KOREAMED SYNAPSE REFID:B37] *** BEGIN ***--><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://www.ncbi.nlm.nih.gov/sites/entrez?db=PubMed&amp;cmd=Retrieve&amp;list_uids=12210908" target="_new"><IMG SRC="image/ReficonPubmed.gif" BORDER="0"></a><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://doi.org/10.1002%2Fmrm.10246" target="_new"><IMG SRC="image/ReficonCrossRef.gif" BORDER="0"></a><!--[KOREAMED SYNAPSE REFID:B37] *** END ***-->
</div>
</td>
</tr>
<tr height="15"><td></td></tr>
<tr>
<td id="B38" valign="top" align="left"><b xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl"><i>38. </i></b></td>
<td valign="top">Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 1993;30:672–679.<div>
<!--[KOREAMED SYNAPSE REFID:B38] *** BEGIN ***--><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://www.ncbi.nlm.nih.gov/sites/entrez?db=PubMed&amp;cmd=Retrieve&amp;list_uids=8139448" target="_new"><IMG SRC="image/ReficonPubmed.gif" BORDER="0"></a><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://doi.org/10.1002%2Fmrm.1910300604" target="_new"><IMG SRC="image/ReficonCrossRef.gif" BORDER="0"></a><!--[KOREAMED SYNAPSE REFID:B38] *** END ***-->
</div>
</td>
</tr>
<tr height="15"><td></td></tr>
<tr>
<td id="B39" valign="top" align="left"><b xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl"><i>39. </i></b></td>
<td valign="top">Cudalbu C, Mlynárik V, Gruetter R. Handling macromolecule signals in the quantification of the neurochemical profile. J Alzheimers Dis 2012;31 Suppl 3:S101–S115.<div>
<!--[KOREAMED SYNAPSE REFID:B39] *** BEGIN ***--><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://www.ncbi.nlm.nih.gov/sites/entrez?db=PubMed&amp;cmd=Retrieve&amp;list_uids=22543852" target="_new"><IMG SRC="image/ReficonPubmed.gif" BORDER="0"></a><!--[KOREAMED SYNAPSE REFID:B39] *** END ***-->
</div>
</td>
</tr>
<tr height="15"><td></td></tr>
<tr>
<td id="B40" valign="top" align="left"><b xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl"><i>40. </i></b></td>
<td valign="top">Penner J, Bartha R. Semi-LASER 1 H MR spectroscopy at 7 Tesla in human brain: metabolite quantification incorporating subject-specific macromolecule removal. Magn Reson Med 2015;74:4–12.<div>
<!--[KOREAMED SYNAPSE REFID:B40] *** BEGIN ***--><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://doi.org/10.1002%2Fmrm.25380" target="_new"><IMG SRC="image/ReficonCrossRef.gif" BORDER="0"></a><!--[KOREAMED SYNAPSE REFID:B40] *** END ***-->
</div>
</td>
</tr>
<tr height="15"><td></td></tr>
<tr>
<td id="B41" valign="top" align="left"><b xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl"><i>41. </i></b></td>
<td valign="top">Kim H, Thompson RB, Hanstock CC, Allen PS. Variability of metabolite yield using STEAM or PRESS sequences in vivo at 3.0 T, illustrated with myo-inositol. Magn Reson Med 2005;53:760–769.<div>
<!--[KOREAMED SYNAPSE REFID:B41] *** BEGIN ***--><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://www.ncbi.nlm.nih.gov/sites/entrez?db=PubMed&amp;cmd=Retrieve&amp;list_uids=15799042" target="_new"><IMG SRC="image/ReficonPubmed.gif" BORDER="0"></a><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://doi.org/10.1002%2Fmrm.20434" target="_new"><IMG SRC="image/ReficonCrossRef.gif" BORDER="0"></a><!--[KOREAMED SYNAPSE REFID:B41] *** END ***-->
</div>
</td>
</tr>
<tr height="15"><td></td></tr>
<tr>
<td id="B42" valign="top" align="left"><b xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl"><i>42. </i></b></td>
<td valign="top">Thompson RB, Allen PS. A new multiple quantum filter design procedure for use on strongly coupled spin systems found in vivo: its application to glutamate. Magn Reson Med 1998;39:762–771.<div>
<!--[KOREAMED SYNAPSE REFID:B42] *** BEGIN ***--><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://www.ncbi.nlm.nih.gov/sites/entrez?db=PubMed&amp;cmd=Retrieve&amp;list_uids=9581608" target="_new"><IMG SRC="image/ReficonPubmed.gif" BORDER="0"></a><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://doi.org/10.1002%2Fmrm.1910390514" target="_new"><IMG SRC="image/ReficonCrossRef.gif" BORDER="0"></a><!--[KOREAMED SYNAPSE REFID:B42] *** END ***-->
</div>
</td>
</tr>
<tr height="15"><td></td></tr>
<tr>
<td id="B43" valign="top" align="left"><b xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl"><i>43. </i></b></td>
<td valign="top">Sørensen OW, Eich GW, Levitt MH, Bodenhausen G, Ernst RR. Product operator-formalism for the description of NMR pulse experiments. Prog NMR Spectrosc 1983;16:163–192.<div>
<!--[KOREAMED SYNAPSE REFID:B43] *** BEGIN ***--><!--[KOREAMED SYNAPSE REFID:B43] *** END ***-->
</div>
</td>
</tr>
<tr height="15"><td></td></tr>
<tr>
<td id="B44" valign="top" align="left"><b xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl"><i>44. </i></b></td>
<td valign="top">Young K, Govindaraju V, Soher BJ, Maudsley AA. Automated spectral analysis I: formation of a priori information by spectral simulation. Magn Reson Med 1998;40:812–815.<div>
<!--[KOREAMED SYNAPSE REFID:B44] *** BEGIN ***--><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://www.ncbi.nlm.nih.gov/sites/entrez?db=PubMed&amp;cmd=Retrieve&amp;list_uids=9840824" target="_new"><IMG SRC="image/ReficonPubmed.gif" BORDER="0"></a><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://doi.org/10.1002%2Fmrm.1910400605" target="_new"><IMG SRC="image/ReficonCrossRef.gif" BORDER="0"></a><!--[KOREAMED SYNAPSE REFID:B44] *** END ***-->
</div>
</td>
</tr>
<tr height="15"><td></td></tr>
<tr>
<td id="B45" valign="top" align="left"><b xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl"><i>45. </i></b></td>
<td valign="top">Young K, Soher BJ, Maudsley AA. Automated spectral analysis II: application of wavelet shrinkage for characterization of non-parameterized signals. Magn Reson Med 1998;40:816–821.<div>
<!--[KOREAMED SYNAPSE REFID:B45] *** BEGIN ***--><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://www.ncbi.nlm.nih.gov/sites/entrez?db=PubMed&amp;cmd=Retrieve&amp;list_uids=9840825" target="_new"><IMG SRC="image/ReficonPubmed.gif" BORDER="0"></a><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://doi.org/10.1002%2Fmrm.1910400606" target="_new"><IMG SRC="image/ReficonCrossRef.gif" BORDER="0"></a><!--[KOREAMED SYNAPSE REFID:B45] *** END ***-->
</div>
</td>
</tr>
<tr height="15"><td></td></tr>
<tr>
<td id="B46" valign="top" align="left"><b xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl"><i>46. </i></b></td>
<td valign="top">Thompson RB, Allen PS. Sources of variability in the response of coupled spins to the PRESS sequence and their potential impact on metabolite quantification. Magn Reson Med 1999;41:1162–1169.<div>
<!--[KOREAMED SYNAPSE REFID:B46] *** BEGIN ***--><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://www.ncbi.nlm.nih.gov/sites/entrez?db=PubMed&amp;cmd=Retrieve&amp;list_uids=10371448" target="_new"><IMG SRC="image/ReficonPubmed.gif" BORDER="0"></a><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://doi.org/10.1002%2F%28SICI%291522-2594%28199906%2941%3A6%3C1162%3A%3AAID-MRM12%3E3.0.CO%3B2-N" target="_new"><IMG SRC="image/ReficonCrossRef.gif" BORDER="0"></a><!--[KOREAMED SYNAPSE REFID:B46] *** END ***-->
</div>
</td>
</tr>
<tr height="15"><td></td></tr>
<tr>
<td id="B47" valign="top" align="left"><b xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl"><i>47. </i></b></td>
<td valign="top">Li Y, Srinivasan R, Ratiney H, Lu Y, Chang SM, Nelson SJ. Comparison of T(1) and T(2) metabolite relaxation times in glioma and normal brain at 3T. J Magn Reson Imaging 2008;28:342–350.<div>
<!--[KOREAMED SYNAPSE REFID:B47] *** BEGIN ***--><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://www.ncbi.nlm.nih.gov/sites/entrez?db=PubMed&amp;cmd=Retrieve&amp;list_uids=18666155" target="_new"><IMG SRC="image/ReficonPubmed.gif" BORDER="0"></a><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://doi.org/10.1002%2Fjmri.21453" target="_new"><IMG SRC="image/ReficonCrossRef.gif" BORDER="0"></a><!--[KOREAMED SYNAPSE REFID:B47] *** END ***-->
</div>
</td>
</tr>
<tr height="15"><td></td></tr>
<tr>
<td id="B48" valign="top" align="left"><b xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl"><i>48. </i></b></td>
<td valign="top">Lange T, Dydak U, Roberts TP, Rowley HA, Bjeljac M, Boesiger P. Pitfalls in lactate measurements at 3T. AJNR Am J Neuroradiol 2006;27:895–901.<div>
<!--[KOREAMED SYNAPSE REFID:B48] *** BEGIN ***--><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://www.ncbi.nlm.nih.gov/sites/entrez?db=PubMed&amp;cmd=Retrieve&amp;list_uids=16611787" target="_new"><IMG SRC="image/ReficonPubmed.gif" BORDER="0"></a><!--[KOREAMED SYNAPSE REFID:B48] *** END ***-->
</div>
</td>
</tr>
<tr height="15"><td></td></tr>
<tr>
<td id="B49" valign="top" align="left"><b xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl"><i>49. </i></b></td>
<td valign="top">Mescher M, Merkle H, Kirsch J, Garwood M, Gruetter R. Simultaneous in vivo spectral editing and water suppression. NMR Biomed 1998;11:266–272.<div>
<!--[KOREAMED SYNAPSE REFID:B49] *** BEGIN ***--><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://www.ncbi.nlm.nih.gov/sites/entrez?db=PubMed&amp;cmd=Retrieve&amp;list_uids=9802468" target="_new"><IMG SRC="image/ReficonPubmed.gif" BORDER="0"></a><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://doi.org/10.1002%2F%28SICI%291099-1492%28199810%2911%3A6%3C266%3A%3AAID-NBM530%3E3.0.CO%3B2-J" target="_new"><IMG SRC="image/ReficonCrossRef.gif" BORDER="0"></a><!--[KOREAMED SYNAPSE REFID:B49] *** END ***-->
</div>
</td>
</tr>
<tr height="15"><td></td></tr>
<tr>
<td id="B50" valign="top" align="left"><b xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl"><i>50. </i></b></td>
<td valign="top">Rothman DL, Behar KL, Hetherington HP, Shulman RG. Homonuclear 1H double-resonance difference spectroscopy of the rat brain in vivo. Proc Natl Acad Sci U S A 1984;81:6330–6334.<div>
<!--[KOREAMED SYNAPSE REFID:B50] *** BEGIN ***--><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://www.ncbi.nlm.nih.gov/sites/entrez?db=PubMed&amp;cmd=Retrieve&amp;list_uids=6149543" target="_new"><IMG SRC="image/ReficonPubmed.gif" BORDER="0"></a><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://doi.org/10.1073%2Fpnas.81.20.6330" target="_new"><IMG SRC="image/ReficonCrossRef.gif" BORDER="0"></a><!--[KOREAMED SYNAPSE REFID:B50] *** END ***-->
</div>
</td>
</tr>
<tr height="15"><td></td></tr>
<tr>
<td id="B51" valign="top" align="left"><b xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl"><i>51. </i></b></td>
<td valign="top">Hetherington HP, Avison MJ, Shulman RG. 1H homonuclear editing of rat brain using semiselective pulses. Proc Natl Acad Sci U S A 1985;82:3115–3118.<div>
<!--[KOREAMED SYNAPSE REFID:B51] *** BEGIN ***--><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://www.ncbi.nlm.nih.gov/sites/entrez?db=PubMed&amp;cmd=Retrieve&amp;list_uids=2987910" target="_new"><IMG SRC="image/ReficonPubmed.gif" BORDER="0"></a><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://doi.org/10.1073%2Fpnas.82.10.3115" target="_new"><IMG SRC="image/ReficonCrossRef.gif" BORDER="0"></a><!--[KOREAMED SYNAPSE REFID:B51] *** END ***-->
</div>
</td>
</tr>
<tr height="15"><td></td></tr>
<tr>
<td id="B52" valign="top" align="left"><b xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl"><i>52. </i></b></td>
<td valign="top">Ernst RR, Bodenhausen G, Wokaun A. In: Principles of nuclear magnetic resonance in one and two dimensions. Oxford: Oxford University Press; 1987. pp. 400-427.<div>
<!--[KOREAMED SYNAPSE REFID:B52] *** BEGIN ***--><!--[KOREAMED SYNAPSE REFID:B52] *** END ***-->
</div>
</td>
</tr>
<tr height="15"><td></td></tr>
<tr>
<td id="B53" valign="top" align="left"><b xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl"><i>53. </i></b></td>
<td valign="top">Aue WP, Bartholdi E, Ernst RR. Two-dimensional spectroscopy. Application to nuclear magnetic resonance. J Chem Phys 1976;64:2229–2246.<div>
<!--[KOREAMED SYNAPSE REFID:B53] *** BEGIN ***--><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://doi.org/10.1063%2F1.432450" target="_new"><IMG SRC="image/ReficonCrossRef.gif" BORDER="0"></a><!--[KOREAMED SYNAPSE REFID:B53] *** END ***-->
</div>
</td>
</tr>
<tr height="15"><td></td></tr>
<tr>
<td id="B54" valign="top" align="left"><b xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl"><i>54. </i></b></td>
<td valign="top">Provencher SW. LCModel &amp; LCMgui user's manual. Web site.  [Accessed January 5, 2016].  <div class="citation-comment">
<a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="http://s-provencher.com/pub/LCModel/manual/manual.pdf" target="_blank">http://s-<wbr/>provencher.com/pub/LCModel/manual/manual.pdf</a>.</div>
<div>
<!--[KOREAMED SYNAPSE REFID:B54] *** BEGIN ***--><!--[KOREAMED SYNAPSE REFID:B54] *** END ***-->
</div>
</td>
</tr>
<tr height="15"><td></td></tr>
<tr>
<td id="B55" valign="top" align="left"><b xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl"><i>55. </i></b></td>
<td valign="top">Opstad KS, Bell BA, Griffiths JR, Howe FA. Toward accurate quantification of metabolites, lipids, and macromolecules in HRMAS spectra of human brain tumor biopsies using LCModel. Magn Reson Med 2008;60:1237–1242.<div>
<!--[KOREAMED SYNAPSE REFID:B55] *** BEGIN ***--><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://www.ncbi.nlm.nih.gov/sites/entrez?db=PubMed&amp;cmd=Retrieve&amp;list_uids=18836999" target="_new"><IMG SRC="image/ReficonPubmed.gif" BORDER="0"></a><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://doi.org/10.1002%2Fmrm.21496" target="_new"><IMG SRC="image/ReficonCrossRef.gif" BORDER="0"></a><!--[KOREAMED SYNAPSE REFID:B55] *** END ***-->
</div>
</td>
</tr>
<tr height="15"><td></td></tr>
<tr>
<td id="B56" valign="top" align="left"><b xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl"><i>56. </i></b></td>
<td valign="top">Naressi A, Couturier C, Devos JM, Janssen M, Mangeat C, de Beer R, et al. Java-based graphical user interface for the MRUI quantitation package. MAGMA 2001;12:141–152.<div>
<!--[KOREAMED SYNAPSE REFID:B56] *** BEGIN ***--><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://www.ncbi.nlm.nih.gov/sites/entrez?db=PubMed&amp;cmd=Retrieve&amp;list_uids=11390270" target="_new"><IMG SRC="image/ReficonPubmed.gif" BORDER="0"></a><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://doi.org/10.1007%2FBF02668096" target="_new"><IMG SRC="image/ReficonCrossRef.gif" BORDER="0"></a><!--[KOREAMED SYNAPSE REFID:B56] *** END ***-->
</div>
</td>
</tr>
<tr height="15"><td></td></tr>
<tr>
<td id="B57" valign="top" align="left"><b xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl"><i>57. </i></b></td>
<td valign="top">Cavassila S, Deval S, Huegen C, van Ormondt D, Graveron-Demilly D. Cramér-Rao bounds: an evaluation tool for quantitation. NMR Biomed 2001;14:278–283.<div>
<!--[KOREAMED SYNAPSE REFID:B57] *** BEGIN ***--><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://www.ncbi.nlm.nih.gov/sites/entrez?db=PubMed&amp;cmd=Retrieve&amp;list_uids=11410946" target="_new"><IMG SRC="image/ReficonPubmed.gif" BORDER="0"></a><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://doi.org/10.1002%2Fnbm.701" target="_new"><IMG SRC="image/ReficonCrossRef.gif" BORDER="0"></a><!--[KOREAMED SYNAPSE REFID:B57] *** END ***-->
</div>
</td>
</tr>
<tr height="15"><td></td></tr>
<tr>
<td id="B58" valign="top" align="left"><b xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl"><i>58. </i></b></td>
<td valign="top">Reitman ZJ, Jin G, Karoly ED, Spasojevic I, Yang J, Kinzler KW, et al. Profiling the effects of isocitrate dehydrogenase 1 and 2 mutations on the cellular metabolome. Proc Natl Acad Sci U S A 2011;108:3270–3275.<div>
<!--[KOREAMED SYNAPSE REFID:B58] *** BEGIN ***--><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://www.ncbi.nlm.nih.gov/sites/entrez?db=PubMed&amp;cmd=Retrieve&amp;list_uids=21289278" target="_new"><IMG SRC="image/ReficonPubmed.gif" BORDER="0"></a><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://doi.org/10.1073%2Fpnas.1019393108" target="_new"><IMG SRC="image/ReficonCrossRef.gif" BORDER="0"></a><!--[KOREAMED SYNAPSE REFID:B58] *** END ***-->
</div>
</td>
</tr>
<tr height="15"><td></td></tr>
<tr>
<td id="B59" valign="top" align="left"><b xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl"><i>59. </i></b></td>
<td valign="top">Terunuma A, Putluri N, Mishra P, Mathé EA, Dorsey TH, Yi M, et al. MYC-driven accumulation of 2-hydroxyglutarate is associated with breast cancer prognosis. J Clin Invest 2014;124:398–412.<div>
<!--[KOREAMED SYNAPSE REFID:B59] *** BEGIN ***--><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://www.ncbi.nlm.nih.gov/sites/entrez?db=PubMed&amp;cmd=Retrieve&amp;list_uids=24316975" target="_new"><IMG SRC="image/ReficonPubmed.gif" BORDER="0"></a><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://doi.org/10.1172%2FJCI71180" target="_new"><IMG SRC="image/ReficonCrossRef.gif" BORDER="0"></a><!--[KOREAMED SYNAPSE REFID:B59] *** END ***-->
</div>
</td>
</tr>
<tr height="15"><td></td></tr>
<tr>
<td id="B60" valign="top" align="left"><b xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl"><i>60. </i></b></td>
<td valign="top">Mardis ER, Ding L, Dooling DJ, Larson DE, McLellan MD, Chen K, et al. Recurring mutations found by sequencing an acute myeloid leukemia genome. N Engl J Med 2009;361:1058–1066.<div>
<!--[KOREAMED SYNAPSE REFID:B60] *** BEGIN ***--><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://www.ncbi.nlm.nih.gov/sites/entrez?db=PubMed&amp;cmd=Retrieve&amp;list_uids=19657110" target="_new"><IMG SRC="image/ReficonPubmed.gif" BORDER="0"></a><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://doi.org/10.1056%2FNEJMoa0903840" target="_new"><IMG SRC="image/ReficonCrossRef.gif" BORDER="0"></a><!--[KOREAMED SYNAPSE REFID:B60] *** END ***-->
</div>
</td>
</tr>
<tr height="15"><td></td></tr>
<tr>
<td id="B61" valign="top" align="left"><b xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl"><i>61. </i></b></td>
<td valign="top">Struys EA, Salomons GS, Achouri Y, Van Schaftingen E, Grosso S, Craigen WJ, et al. Mutations in the D-2-hydroxyglutarate dehydrogenase gene cause D-2-hydroxyglutaric aciduria. Am J Hum Genet 2005;76:358–360.<div>
<!--[KOREAMED SYNAPSE REFID:B61] *** BEGIN ***--><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://www.ncbi.nlm.nih.gov/sites/entrez?db=PubMed&amp;cmd=Retrieve&amp;list_uids=15609246" target="_new"><IMG SRC="image/ReficonPubmed.gif" BORDER="0"></a><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://doi.org/10.1086%2F427890" target="_new"><IMG SRC="image/ReficonCrossRef.gif" BORDER="0"></a><!--[KOREAMED SYNAPSE REFID:B61] *** END ***-->
</div>
</td>
</tr>
<tr height="15"><td></td></tr>
<tr>
<td id="B62" valign="top" align="left"><b xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl"><i>62. </i></b></td>
<td valign="top">Green A, Beer P. Somatic mutations of IDH1 and IDH2 in the leukemic transformation of myeloproliferative neoplasms. N Engl J Med 2010;362:369–370.<div>
<!--[KOREAMED SYNAPSE REFID:B62] *** BEGIN ***--><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://www.ncbi.nlm.nih.gov/sites/entrez?db=PubMed&amp;cmd=Retrieve&amp;list_uids=20107228" target="_new"><IMG SRC="image/ReficonPubmed.gif" BORDER="0"></a><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://doi.org/10.1056%2FNEJMc0910063" target="_new"><IMG SRC="image/ReficonCrossRef.gif" BORDER="0"></a><!--[KOREAMED SYNAPSE REFID:B62] *** END ***-->
</div>
</td>
</tr>
<tr height="15"><td></td></tr>
<tr>
<td id="B63" valign="top" align="left"><b xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl"><i>63. </i></b></td>
<td valign="top">Ward PS, Patel J, Wise DR, Abdel-Wahab O, Bennett BD, Coller HA, et al. The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate. Cancer Cell 2010;17:225–234.<div>
<!--[KOREAMED SYNAPSE REFID:B63] *** BEGIN ***--><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://www.ncbi.nlm.nih.gov/sites/entrez?db=PubMed&amp;cmd=Retrieve&amp;list_uids=20171147" target="_new"><IMG SRC="image/ReficonPubmed.gif" BORDER="0"></a><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://doi.org/10.1016%2Fj.ccr.2010.01.020" target="_new"><IMG SRC="image/ReficonCrossRef.gif" BORDER="0"></a><!--[KOREAMED SYNAPSE REFID:B63] *** END ***-->
</div>
</td>
</tr>
<tr height="15"><td></td></tr>
<tr>
<td id="B64" valign="top" align="left"><b xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl"><i>64. </i></b></td>
<td valign="top">Kang MR, Kim MS, Oh JE, Kim YR, Song SY, Seo SI, et al. Mutational analysis of IDH1 codon 132 in glioblastomas and other common cancers. Int J Cancer 2009;125:353–355.<div>
<!--[KOREAMED SYNAPSE REFID:B64] *** BEGIN ***--><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://www.ncbi.nlm.nih.gov/sites/entrez?db=PubMed&amp;cmd=Retrieve&amp;list_uids=19378339" target="_new"><IMG SRC="image/ReficonPubmed.gif" BORDER="0"></a><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://doi.org/10.1002%2Fijc.24379" target="_new"><IMG SRC="image/ReficonCrossRef.gif" BORDER="0"></a><!--[KOREAMED SYNAPSE REFID:B64] *** END ***-->
</div>
</td>
</tr>
<tr height="15"><td></td></tr>
<tr>
<td id="B65" valign="top" align="left"><b xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl"><i>65. </i></b></td>
<td valign="top">Sjöblom T, Jones S, Wood LD, Parsons DW, Lin J, Barber TD, et al. The consensus coding sequences of human breast and colorectal cancers. Science 2006;314:268–274.<div>
<!--[KOREAMED SYNAPSE REFID:B65] *** BEGIN ***--><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://doi.org/10.1126%2Fscience.1133427" target="_new"><IMG SRC="image/ReficonCrossRef.gif" BORDER="0"></a><!--[KOREAMED SYNAPSE REFID:B65] *** END ***-->
</div>
</td>
</tr>
<tr height="15"><td></td></tr>
<tr>
<td id="B66" valign="top" align="left"><b xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl"><i>66. </i></b></td>
<td valign="top">Lopez GY, Reitman ZJ, Solomon D, Waldman T, Bigner DD, McLendon RE, et al. IDH1(R132) mutation identified in one human melanoma metastasis, but not correlated with metastases to the brain. Biochem Biophys Res Commun 2010;398:585–587.<div>
<!--[KOREAMED SYNAPSE REFID:B66] *** BEGIN ***--><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://www.ncbi.nlm.nih.gov/sites/entrez?db=PubMed&amp;cmd=Retrieve&amp;list_uids=20603105" target="_new"><IMG SRC="image/ReficonPubmed.gif" BORDER="0"></a><a xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:php="http://php.net/xsl" href="https://doi.org/10.1016%2Fj.bbrc.2010.06.125" target="_new"><IMG SRC="image/ReficonCrossRef.gif" BORDER="0"></a><!--[KOREAMED SYNAPSE REFID:B66] *** END ***-->
</div>
</td>
</tr>
<tr height="15"><td></td></tr>
</table>


</div>
									</div>
								</TD>
							</TR>
							</TBODY>
						</TABLE>
					</td>
				</tr>
				</table>
			</td>
		</tr>
	</table>	
	
	</div>
		
	<div id="ArticleContentsPortlet">
			
		<div class="portlet_crossmark">
			<div aria-live="assertive">
				<style>
					#crossmark_bottom_aligner {
						display: inline-block;
						height: 3.2em;
						vertical-align: bottom;
						width: 0px;
					}
				</style>
				<div id="crossmark_bottom_aligner"></div>
				<div class="portlet_content" aria-hidden="false">
				<span><script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script><a data-target="crossmark"><img src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg" width="150"/></a></span>				</div>
			</div>					
		</div>
			
		<div id="portlet_content_Format" class="portlet">
			<div class="portlet_head">
				<div class="portlet_title">Formats:</div>
			</div>
			<div aria-live="assertive">
				<div class="portlet_content" aria-hidden="false">
					<ul>
<li><img width="12" src="image/icon-citation.jpg"><A href="DownloadCitation.php?id=553103&code=0068KJR" ONCLICK="javascript:PopUpOnParentRight( this.href, 750, 450); return false;">Citation</A></li><li><img width="12" src="image/side-abstract.jpg"><A href="search.php?where=aview&id=10.3348/kjr.2016.17.5.620&code=0068KJR&vmode=AONLY">Abstract</A></li><li><img width="12" src="image/side-article.jpg">Article</li><li><img width="12" src="image/side-pdf.jpg"><A href="Synapse/Data/PDFData/0068KJR/kjr-17-620.pdf">PDF</A></li><li><img width="12" src="image/side-pubreader.jpg"><A href="search.php?where=aview&id=10.3348/kjr.2016.17.5.620&code=0068KJR&vmode=PUBREADER">PubReader</A></li><li><img width="12" src="image/side-epub.jpg"><A href="epub/10.3348/kjr.2016.17.5.620">ePub</A></li><li><img width="12" src="image/side-figtbl.jpg"><A href="search.php?where=aview&id=10.3348/kjr.2016.17.5.620&code=0068KJR&vmode=FT">Figures + Tables</A></li><li><img width="12" src="image/side-reference.jpg"><A href="search.php?where=aview&id=10.3348/kjr.2016.17.5.620&code=0068KJR&vmode=REF">References</A></li>					</ul>
				</div>
			</div>
		</div>
		
			
			
		<div class="portlet">
			<div class="portlet_head">
				<div class="portlet_title">Cited by Metrics:</div>
			</div>
			<div aria-live="assertive">
				<div class="portlet_content" aria-hidden="false">
					<ul>
<li><a href="CitedBy.php?id=553103&code=0068KJR" onClick="javascript:PopUpOnParentRight( this.href, 750, 400 ); return false;"><img src="image/icon_synapse.gif" border="0" align="absbottom"><img src="image/icon_CrossRef.gif" border="0" align="absbottom">&nbsp;(2)</a></li><li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/27587950/citedby" target="_blank"><font color="#004f8a">PubMed Central</font>&nbsp;(1)</a></li><li><a href="https://scholar.google.com/scholar?cites=http%3A%2F%2Fdx.doi.org%2F10.3348%2Fkjr.2016.17.5.620" target="_blank"><FONT color=#324eba>G</FONT><FONT color=#e92736>o</FONT><FONT color=#feac06>o</FONT><FONT color=#324eba>g</FONT><FONT color=#0cb225>l</FONT><FONT color=#e92736>e</FONT>&nbsp;<FONT color=#324eba>Scholar</FONT></a></li>					</ul>
				</div>
			</div>					
		</div>		

		
		<div id="portlet_content_MeSH" class="portlet">	
			
			<div class="portlet_head">
				<div class="portlet_title"><span><img src="image/icon-mesh.jpg" style="vertical-align:middle;"/>MeSH Terms:</span><span style="float:right;"><img src="image/icon_question.gif" title="If any of the MeSH terms below is not appropriate, click the pin next to the MeSH term. Thanks for your support!" style="padding-left:6px; padding-right:5px; margin-right:-2em; vertical-align:middle;"/></span></div>
			</div>
			<div aria-live="assertive">
				<div class="portlet_content" aria-hidden="false">
					<ul>
<li class="MeSHMark">
							<span style="align:left;"><a href="https://www.koreamed.org/SearchBasic.php?QY=%22Biochemistry%22+%5BMH%5D&DisplaySearchResult=1" target="_blank"><div>Biochemistry</div></a></span>
							<span style="float:right; left-margin:-1em; display: inline-block;" data-id="10.3348/kjr.2016.17.5.620" data-type="MESH" data-mesh="Biochemistry"><a href="#" class="MeSHTermMark" style="BORDER-BOTTOM: black 0px dotted;"><img src="image/pin-off.gif" title="Mark as inappropriate"/></a></span>
							</li><li class="MeSHMark">
							<span style="align:left;"><a href="https://www.koreamed.org/SearchBasic.php?QY=%22Diagnosis%22+%5BMH%5D&DisplaySearchResult=1" target="_blank"><div>Diagnosis</div></a></span>
							<span style="float:right; left-margin:-1em; display: inline-block;" data-id="10.3348/kjr.2016.17.5.620" data-type="MESH" data-mesh="Diagnosis"><a href="#" class="MeSHTermMark" style="BORDER-BOTTOM: black 0px dotted;"><img src="image/pin-off.gif" title="Mark as inappropriate"/></a></span>
							</li><li class="MeSHMark">
							<span style="align:left;"><a href="https://www.koreamed.org/SearchBasic.php?QY=%22Glioma%2A%22+%5BMAJR%5D&DisplaySearchResult=1" target="_blank"><div>Glioma*</div></a></span>
							<span style="float:right; left-margin:-1em; display: inline-block;" data-id="10.3348/kjr.2016.17.5.620" data-type="MESH" data-mesh="Glioma*"><a href="#" class="MeSHTermMark" style="BORDER-BOTTOM: black 0px dotted;"><img src="image/pin-off.gif" title="Mark as inappropriate"/></a></span>
							</li><li class="MeSHMark">
							<span style="align:left;"><a href="https://www.koreamed.org/SearchBasic.php?QY=%22Isocitrate+Dehydrogenase%22+%5BMH%5D&DisplaySearchResult=1" target="_blank"><div>Isocitrate Dehydrogenase</div></a></span>
							<span style="float:right; left-margin:-1em; display: inline-block;" data-id="10.3348/kjr.2016.17.5.620" data-type="MESH" data-mesh="Isocitrate Dehydrogenase"><a href="#" class="MeSHTermMark" style="BORDER-BOTTOM: black 0px dotted;"><img src="image/pin-off.gif" title="Mark as inappropriate"/></a></span>
							</li><li class="MeSHMark">
							<span style="align:left;"><a href="https://www.koreamed.org/SearchBasic.php?QY=%22Magnetic+Resonance+Spectroscopy%22+%5BMH%5D&DisplaySearchResult=1" target="_blank"><div>Magnetic Resonance Spectroscopy</div></a></span>
							<span style="float:right; left-margin:-1em; display: inline-block;" data-id="10.3348/kjr.2016.17.5.620" data-type="MESH" data-mesh="Magnetic Resonance Spectroscopy"><a href="#" class="MeSHTermMark" style="BORDER-BOTTOM: black 0px dotted;"><img src="image/pin-off.gif" title="Mark as inappropriate"/></a></span>
							</li><li class="MeSHMark">
							<span style="align:left;"><a href="https://www.koreamed.org/SearchBasic.php?QY=%22Proton+Magnetic+Resonance+Spectroscopy%2A%22+%5BMAJR%5D&DisplaySearchResult=1" target="_blank"><div>Proton Magnetic Resonance Spectroscopy*</div></a></span>
							<span style="float:right; left-margin:-1em; display: inline-block;" data-id="10.3348/kjr.2016.17.5.620" data-type="MESH" data-mesh="Proton Magnetic Resonance Spectroscopy*"><a href="#" class="MeSHTermMark" style="BORDER-BOTTOM: black 0px dotted;"><img src="image/pin-off.gif" title="Mark as inappropriate"/></a></span>
							</li><li class="MeSHMark">
							<span style="align:left;"><a href="https://www.koreamed.org/SearchBasic.php?QY=%22Protons%2A%22+%5BMAJR%5D&DisplaySearchResult=1" target="_blank"><div>Protons*</div></a></span>
							<span style="float:right; left-margin:-1em; display: inline-block;" data-id="10.3348/kjr.2016.17.5.620" data-type="MESH" data-mesh="Protons*"><a href="#" class="MeSHTermMark" style="BORDER-BOTTOM: black 0px dotted;"><img src="image/pin-off.gif" title="Mark as inappropriate"/></a></span>
							</li>					</ul>
				</div>
			</div>
				
				
			<div class="portlet_subhead">
				<div class="portlet_title"><span style="padding-left:19px;"></span>Substances:</div>
			</div>
			<div aria-live="assertive">
				<div class="portlet_content" aria-hidden="false">
					<ul>
<li class="MeSHMark">
						<span style="align:left;"><a href="https://www.koreamed.org/SearchBasic.php?QY=%22Isocitrate+Dehydrogenase%22+%5BMH%5D&DisplaySearchResult=1" target="_blank"><div>Isocitrate Dehydrogenase</div></a></span>
						<span style="float:right; left-margin:-1em; display: inline-block;" data-id="10.3348/kjr.2016.17.5.620" data-type="SUBSTANCES" data-mesh="Isocitrate Dehydrogenase"><a href="#" class="MeSHTermMark" style="BORDER-BOTTOM: black 0px dotted;"><img src="image/pin-off.gif" title="Mark as inappropriate"/></a></span>
						</li><li class="MeSHMark">
						<span style="align:left;"><a href="https://www.koreamed.org/SearchBasic.php?QY=%22Protons%22+%5BMH%5D&DisplaySearchResult=1" target="_blank"><div>Protons</div></a></span>
						<span style="float:right; left-margin:-1em; display: inline-block;" data-id="10.3348/kjr.2016.17.5.620" data-type="SUBSTANCES" data-mesh="Protons"><a href="#" class="MeSHTermMark" style="BORDER-BOTTOM: black 0px dotted;"><img src="image/pin-off.gif" title="Mark as inappropriate"/></a></span>
						</li><li class="MeSHMark">
						<span style="align:left;"><a href="https://www.koreamed.org/SearchBasic.php?QY=%22alpha-hydroxyglutarate%22+%5BSCR%5D&DisplaySearchResult=1" target="_blank"><div>alpha-hydroxyglutarate</div></a></span>
						<span style="float:right; left-margin:-1em; display: inline-block;" data-id="10.3348/kjr.2016.17.5.620" data-type="SUBSTANCES" data-mesh="alpha-hydroxyglutarate"><a href="#" class="MeSHTermMark" style="BORDER-BOTTOM: black 0px dotted;"><img src="image/pin-off.gif" title="Mark as inappropriate"/></a></span>
						</li><li class="MeSHMark">
						<span style="align:left;"><a href="https://www.koreamed.org/SearchBasic.php?QY=%22isocitric+acid%22+%5BSCR%5D&DisplaySearchResult=1" target="_blank"><div>isocitric acid</div></a></span>
						<span style="float:right; left-margin:-1em; display: inline-block;" data-id="10.3348/kjr.2016.17.5.620" data-type="SUBSTANCES" data-mesh="isocitric acid"><a href="#" class="MeSHTermMark" style="BORDER-BOTTOM: black 0px dotted;"><img src="image/pin-off.gif" title="Mark as inappropriate"/></a></span>
						</li>					</ul>
				</div>
			</div>	
		</div>

			
		<script>
		
			jQuery(document).ready(function() {
			    jQuery('#mycarousel_Figure').jcarousel({
			        vertical: true,	        
			        scroll: 1
			    });
			});	
			
		</script>
		
		<div class="portlet">
			<div class="portlet_head">
				<div class="portlet_title">Figures:</div>
			</div>
			<div aria-live="assertive">
				<div class="portlet_content portlet_content_carousel" aria-hidden="false">
				
					<div>						
						<ul id="mycarousel_Figure" class="jcarousel-skin-tango">
<li><a href="ViewImage.php?Type=F&aid=553103&id=F1&afn=68_KJR_17_5_620&fn=kjr-17-620-g001_0068KJR" target=_blank><img src="ArticleImage/0068KJR/kjr-17-620-g001.jpg" alt="" border="1" width="120" height="80" /></a></li><li><a href="ViewImage.php?Type=F&aid=553103&id=F2&afn=68_KJR_17_5_620&fn=kjr-17-620-g002_0068KJR" target=_blank><img src="ArticleImage/0068KJR/kjr-17-620-g002.jpg" alt="" border="1" width="120" height="80" /></a></li><li><a href="ViewImage.php?Type=F&aid=553103&id=F3&afn=68_KJR_17_5_620&fn=kjr-17-620-g003_0068KJR" target=_blank><img src="ArticleImage/0068KJR/kjr-17-620-g003.jpg" alt="" border="1" width="120" height="80" /></a></li><li><a href="ViewImage.php?Type=F&aid=553103&id=F4&afn=68_KJR_17_5_620&fn=kjr-17-620-g004_0068KJR" target=_blank><img src="ArticleImage/0068KJR/kjr-17-620-g004.jpg" alt="" border="1" width="120" height="80" /></a></li><li><a href="ViewImage.php?Type=F&aid=553103&id=F5&afn=68_KJR_17_5_620&fn=kjr-17-620-g005_0068KJR" target=_blank><img src="ArticleImage/0068KJR/kjr-17-620-g005.jpg" alt="" border="1" width="120" height="80" /></a></li>						</ul>	
					</div>
					<div>
						<ul id="portlet_content_carousel">
							<li><a href="search.php?where=aview&id=10.3348/kjr.2016.17.5.620&code=0068KJR&vmode=FT">Show all...</a></li>
						</ul>					
					</div>
				</div>
			</div>
		</div>
			
			
		<script>
		
			jQuery(document).ready(function() {
			    jQuery('#mycarousel_Table').jcarousel({
			        vertical: true,
					scroll: 1
			    });
			});
			
		</script>
		
		<div class="portlet">
			<div class="portlet_head">
				<div class="portlet_title">Tables:</div>
			</div>
			<div aria-live="assertive">
				<div class="portlet_content portlet_content_carousel" aria-hidden="false">
					<div>						
						<ul id="mycarousel_Table" class="jcarousel-skin-tango">
<li><a href="ViewImage.php?Type=T&aid=553103&id=T1&afn=68_KJR_17_5_620&fn=kjr-17-620-i001_0068KJR" target=_blank><img src="ArticleImage/0068KJR/kjr-17-620-i001.jpg" alt="" border="1" width="120" height="80" /></a></li>						</ul>
					</div>
					<div>
						<ul id="portlet_content_carousel">
							<li><a href="search.php?where=aview&id=10.3348/kjr.2016.17.5.620&code=0068KJR&vmode=FT">Show all...</a></li>
						</ul>					
					</div>
				</div>
			</div>
		</div>
		
		<div class="portlet">
			<div class="portlet_head">
				<div class="portlet_title">Links to:</div>
			</div>
			<div aria-live="assertive">
				<div class="portlet_content" aria-hidden="false">
					<ul id="portlet_content_LinksTo">
<li><A href="LinkOutX.php?kmid=2355826&pid=0000-0068&lid=1&au=Kim H" target="_new"><img src="image/side-journal.jpg" border="0" align="absmiddle">the Journal</A></li><li><A HREF="https://www.koreamed.org/SearchBasic.php?RID=2355826&DT=1" target="_blank"><img src="image/side-koreamed.jpg" border="0" align="absmiddle">KoreaMed</a></li><li><A HREF="https://www.komci.org/GSResult.php?RID=2355826&DT=1" target="_blank"><img src="image/side-komci.jpg" border="0" align="absmiddle">KoMCI</a></li><li><A HREF="https://www.ncbi.nlm.nih.gov/pubmed/27587950" target="_blank"><img src="image/side-pubmed.jpg" border="0" align="absmiddle">MEDLINE/PubMed</a></li><li><A HREF="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5007388/?report=classic" target="_blank"><img src="image/side-pmc.jpg" border="0" align="absmiddle">PubMed Central</a></li><li><A HREF="https://www.ncbi.nlm.nih.gov/pubmed?LinkName=pubmed_pubmed&from_uid=27587950" target="_blank"><img src="image/side-related-pubmed.jpg" border="0" align="absmiddle">Related citations in PubMed</a></li>					</ul>
				</div>
			</div>			
		</div>			
		
		<div class="portlet">
			<div class="portlet_head">
				<div class="portlet_title">Export:</div>
			</div>
			<div aria-live="assertive">
				<div class="portlet_content" aria-hidden="false">
					<ul id="portlet_content_Export">
						<li><a href="DownloadCitation.php?id=553103&code=0068KJR" onClick="javascript:PopUpOnParentRight( this.href, 750, 450); return false;"><img title="Download Citation" src="image/icon-citation.jpg" border="0" align="absmiddle">Download Citation</a></li>
						<li><A HREF="ShareContents.php?where=aview&type=email&id=10.3348/kjr.2016.17.5.620&code=0068KJR" onClick="javascript:PopUpOnParentRight( this.href, 750, 500 ); return false;"><IMG title="Email this article" SRC="image/icon-email-14.gif" border="0" align="absmiddle">E-mail</A></li>
						<li><A HREF="ShareContents.php?where=aview&type=tw&id=10.3348/kjr.2016.17.5.620" onClick="javascript:PopUpOnParentRight( this.href, 600, 500 ); return false;"><IMG title="Tweet this!" SRC="image/icon-twitter-14.gif" border="0" align="absmiddle">Twitter</A></li>
						<li><A HREF="ShareContents.php?where=aview&type=fb&id=10.3348/kjr.2016.17.5.620" onClick="javascript:PopUpOnParentRight( this.href, 800, 500 ); return false;"><IMG title="Add to Facebook"  SRC="image/icon-facebook-14.gif" border="0" align="absmiddle">Facebook</A></li>
					</ul>
				</div>
			</div>
		</div>
		<div class="portlet">
			<div class="portlet_head">
				<div class="portlet_title"><img src="image/icon-fundref.jpg" border="0" align="absmiddle">Funding Information:</div>
			</div>
			<div aria-live="assertive">
				<div class="portlet_content" aria-hidden="false">
					<ul id="portlet_content_FUNDREF">
<li class="more_margin FundRef"><div class="FunderSource"><span class="AwardId">Ministry of Health and Welfare</span><br><span class="AwardId">HI13C0015</span><BR></div></li><li class="more_margin FundRef"><div class="FunderSource"><span class="AwardId">Seoul National University College of Medicine</span><br><span class="AwardId">800-20130068</span><BR></div></li>					</ul>
				</div>
			</div>
		</div>
			
	</div>	



	    </td>
		  </tr>
		  <tr>
            <td height="100" align="right" valign="bottom"><img src="image/copyright.gif"></td>
		  </tr>
		</table>
		</td>
		
		<!-- END : ���� �˻� ��� �� ������ ��� -->
	</tr>
</table>
    </td>
  </tr>
</table>

	</div>
	<!-- GRID -->	
	</div>
</body>
</html>
